Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
ASPC.stem_like_progenitor: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 2,337 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | C21orf58 levels | PROLV000231 | 94.30 | Protein levels | Hepatocyte | 0 | 4 | 10 | 17 | |
| 2 | FGR levels | PROLV000804 | 88.71 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 3 | Operation, hernia | GASTR000040 | 88.58 | Gastrointestinal | Adipose | 21 | 2 | 5 | 9 | |
| 4 | HSPG2/IGFBP6 ratio | PRORT001307 | 88.08 | Protein ratios | Adipose | 15 | 3 | 9 | 18 | |
| 5 | TNXB levels | PROLV002085 | 87.15 | Protein levels | Stromal / connective | 56 | 4 | 7 | 22 | |
| 6 | CBLN4 levels | PROLV000272 | 84.24 | Protein levels | Adipose | 11 | 2 | 8 | 9 | |
| 7 | Hyperthyroidism, subclinical in pregnancy | ENDOC000011 | 81.61 | Endocrine | Adipose | 1 | 3 | 9 | 14 | |
| 8 | ROBO2 levels | PROLV001750 | 76.79 | Protein levels | Adipose | 69 | 5 | 10 | 24 | |
| 9 | Heel quantitative ultrasound | MSKEL000005 | 75.82 | Musculoskeletal | Stromal / connective | 361 | 3 | 8 | 12 | |
| 10 | Nerve entrapment syndrome | NEURO000028 | 67.11 | Neurologic | Stromal / connective | 19 | 4 | 7 | 12 | |
| 11 | Hip index | BMORP000012 | 64.46 | Body morphology | Adipose | 121 | 3 | 4 | 14 | |
| 12 | VNN2 levels | PROLV002165 | 63.73 | Protein levels | Myeloid | 72 | 2 | 11 | 14 | |
| 13 | ROBO2/SCARF2 ratio | PRORT001745 | 62.00 | Protein ratios | Adipose | 12 | 4 | 10 | 12 | |
| 14 | Bone mineral density | MSKEL000004 | 58.15 | Musculoskeletal | Stromal / connective | 350 | 3 | 8 | 10 | |
| 15 | IGFBP6/SMOC2 ratio | PRORT001338 | 57.37 | Protein ratios | Adipose | 2 | 3 | 8 | 13 | |
| 16 | Waist circumference, adjusted for BMI | BMORP000006 | 54.67 | Body morphology | Stromal / connective | 314 | 3 | 3 | 9 | |
| 17 | Hernia | GASTR000008 | 50.57 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 18 | COL6A3/SMOC2 ratio | PRORT000700 | 48.50 | Protein ratios | Adipose | 34 | 4 | 6 | 17 | |
| 19 | Arm impedance | BCOMP000013 | 46.60 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 20 | CTSD/PRCP ratio | PRORT000799 | 46.54 | Protein ratios | Hepatocyte | 16 | 2 | 10 | 21 | |
| 21 | Waist-hip ratio | BMORP000014 | 46.19 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 22 | A body shape index, ABSI | BMORP000001 | 46.06 | Body morphology | Stromal / connective | 203 | 3 | 6 | 12 | |
| 23 | BCAN/DPP6 ratio | PRORT000215 | 42.89 | Protein ratios | Stromal / connective | 0 | 5 | 11 | 20 | |
| 24 | RET levels | PROLV001724 | 42.85 | Protein levels | Stromal / connective | 18 | 5 | 10 | 21 | |
| 25 | COL6A3/CST3 ratio | PRORT000696 | 42.62 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 26 | Fasciectomy | MSKEL000045 | 42.36 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 27 | Pelvic morphology | BMORP000021 | 41.29 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 28 | Bone fragility disorder | MSKEL000007 | 41.08 | Musculoskeletal | Adipose | 23 | 5 | 15 | 25 | |
| 29 | NCR3 levels | PROLV001383 | 40.46 | Protein levels | Adipose | — | 3 | 10 | 28 | |
| 30 | Body proportion | BMORP000019 | 39.61 | Body morphology | Stromal / connective | 71 | 3 | 8 | 8 | |
| 31 | Spinal deformity | MSKEL000077 | 39.28 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 13 | |
| 32 | Corneal properties | OPHTH000010 | 38.16 | Ophthalmic | Stromal / connective | 279 | 3 | 5 | 10 | |
| 33 | Whole body impedance | BCOMP000007 | 37.52 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 34 | Fibroblastic disorder | MSKEL000064 | 37.41 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 35 | ZNRF4 levels | PROLV002214 | 37.01 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 36 | Intraocular pressure | OPHTH000011 | 36.94 | Ophthalmic | Stromal / connective | 184 | 4 | 6 | 10 | |
| 37 | EGFR/FAP ratio | PRORT001000 | 36.47 | Protein ratios | Adipose | 52 | 4 | 8 | 17 | |
| 38 | Intestinal infection | IMMUN000066 | 36.19 | Immunologic | Vascular | 5 | 3 | 7 | 15 | |
| 39 | VCAN levels | PROLV002156 | 35.61 | Protein levels | Adipose | 116 | 3 | 8 | 21 | |
| 40 | Acquired foot deformities | MSKEL000052 | 35.05 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 41 | Lean mass | BCOMP000009 | 34.71 | Body composition | Stromal / connective | 897 | 4 | 7 | 8 | |
| 42 | Medication, antiglaucoma | OPHTH000014 | 34.49 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 43 | CD200R1 levels | PROLV000317 | 33.47 | Protein levels | Adipose | 54 | 2 | 5 | 14 | |
| 44 | Prolapse, pelvic organ | REPRO000025 | 33.15 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 45 | Leukoencephalopathy | NEURO000004 | 32.90 | Neurologic | Stromal / connective | 2 | 2 | 10 | 7 | |
| 46 | EIF4G1/TBC1D23 ratio | PRORT001014 | 32.87 | Protein ratios | Adipose | 1 | 3 | 7 | 13 | |
| 47 | Corneal keratometry | OPHTH000006 | 30.99 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 48 | PSPN levels | PROLV001661 | 30.58 | Protein levels | Stromal / connective | 26 | 4 | 9 | 11 | |
| 49 | COL4A1 levels | PROLV000490 | 30.04 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 50 | Leg impedance | BCOMP000016 | 29.73 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 51 | Musculoskeletal soft tissue disorder | MSKEL000029 | 29.41 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 52 | DPP6/SEZ6L2 ratio | PRORT000948 | 29.21 | Protein ratios | Myeloid | 37 | 4 | 14 | 16 | |
| 53 | Ankle spacing width | MSKEL000056 | 28.17 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 54 | Hip circumference, adjusted for BMI | BMORP000005 | 28.13 | Body morphology | Stromal / connective | 326 | 5 | 6 | 10 | |
| 55 | DPP4/ITGB1 ratio | PRORT000944 | 28.08 | Protein ratios | Myeloid | 11 | 3 | 12 | 25 | |
| 56 | RFC4 levels | PROLV001726 | 28.03 | Protein levels | Stromal / connective | 1 | 4 | 14 | 19 | |
| 57 | AOC3 levels | PROLV000109 | 27.94 | Protein levels | Myeloid | 116 | 4 | 13 | 22 | |
| 58 | FAP levels | PROLV000769 | 27.25 | Protein levels | Adipose | 78 | 7 | 12 | 27 | |
| 59 | SLITRK6 levels | PROLV001890 | 26.34 | Protein levels | Adipose | 4 | 2 | 11 | 17 | |
| 60 | Diverticular disease | GASTR000011 | 26.34 | Gastrointestinal | Stromal / connective | 95 | 3 | 6 | 17 | |
| 61 | Joint disorder | MSKEL000015 | 26.24 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 62 | CDON/SCARA5 ratio | PRORT000581 | 26.23 | Protein ratios | Adipose | 51 | 3 | 7 | 11 | |
| 63 | HSPG2/SMOC2 ratio | PRORT001309 | 26.21 | Protein ratios | Stromal / connective | 32 | 4 | 9 | 16 | |
| 64 | Eye disorder | OPHTH000008 | 26.00 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 65 | EFEMP1/TGFBR3 ratio | PRORT000988 | 25.39 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 66 | HHIP levels | PROLV000969 | 25.33 | Protein levels | B / plasma cell | 0 | 3 | 9 | 16 | |
| 67 | CD164/PARK7 ratio | PRORT000389 | 25.18 | Protein ratios | Neural / glial | 0 | 6 | 10 | 25 | |
| 68 | Spondylolisthesis or spondylolysis | MSKEL000079 | 25.17 | Musculoskeletal | Stromal / connective | 0 | 3 | 5 | 13 | |
| 69 | CLMP/PIK3IP1 ratio | PRORT000669 | 25.11 | Protein ratios | Adipose | 1 | 3 | 6 | 10 | |
| 70 | BOC levels | PROLV000207 | 24.54 | Protein levels | Stromal / connective | 7 | 5 | 15 | 42 | |
| 71 | Height | BMORP000009 | 24.37 | Body morphology | Stromal / connective | 3,280 | 3 | 4 | 6 | |
| 72 | Forced vital capacity, FVC | RESPI000020 | 24.32 | Respiratory | Stromal / connective | 487 | 4 | 6 | 8 | |
| 73 | PILRA/TNFRSF1A ratio | PRORT001668 | 24.18 | Protein ratios | Adipose | 42 | 2 | 9 | 13 | |
| 74 | ENG levels | PROLV000704 | 24.10 | Protein levels | Adipose | 10 | 4 | 12 | 30 | |
| 75 | PECAM1/SOD2 ratio | PRORT001662 | 24.03 | Protein ratios | Myeloid | 17 | 5 | 13 | 18 | |
| 76 | CD34 levels | PROLV000336 | 23.59 | Protein levels | Stromal / connective | 67 | 3 | 10 | 21 | |
| 77 | ITGAM/ITGAV ratio | PRORT001375 | 23.41 | Protein ratios | Myeloid | 72 | 4 | 16 | 25 | |
| 78 | CTSO/IGF2R ratio | PRORT000803 | 23.39 | Protein ratios | Hepatocyte | 20 | 4 | 13 | 26 | |
| 79 | Body size, adult | BMORP000003 | 23.35 | Body morphology | Stromal / connective | 300 | 3 | 6 | 8 | |
| 80 | Trunk fat percentage | BCOMP000018 | 23.32 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 81 | CNTN1 levels | PROLV000475 | 23.19 | Protein levels | Stromal / connective | 121 | 4 | 10 | 25 | |
| 82 | CDON levels | PROLV000385 | 23.11 | Protein levels | Granulosa cell | 4 | 5 | 10 | 14 | |
| 83 | FNDC1 levels | PROLV000820 | 23.08 | Protein levels | Hepatocyte | 14 | 3 | 13 | 22 | |
| 84 | COL6A3/COLEC12 ratio | PRORT000695 | 22.85 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 85 | LTBP2 levels | PROLV001242 | 22.78 | Protein levels | Myeloid | 145 | 4 | 14 | 23 | |
| 86 | MATN2 levels | PROLV001277 | 22.24 | Protein levels | Stromal / connective | 78 | 3 | 6 | 14 | |
| 87 | Metabolic disorder | METBL000014 | 22.11 | Metabolic | Hepatocyte | 114 | 1 | 7 | 15 | |
| 88 | PSG1 levels | PROLV001656 | 21.80 | Protein levels | Myeloid | 41 | 4 | 13 | 21 | |
| 89 | DLK1/FAP ratio | PRORT000911 | 21.32 | Protein ratios | Adipose | 26 | 4 | 8 | 25 | |
| 90 | TNC levels | PROLV002052 | 21.16 | Protein levels | Adipose | 35 | 2 | 6 | 11 | |
| 91 | Benign neoplasm, Endocrine | MALIG000003 | 21.06 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 92 | ADAMTSL2 levels | PROLV000036 | 21.01 | Protein levels | Hepatocyte | 72 | 3 | 14 | 23 | |
| 93 | Barrett's oesophagus | GASTR000046 | 20.94 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 94 | Hand grip strength | MSKEL000030 | 20.66 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 95 | Carotid intima-media thickness | VASCU000053 | 20.65 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 96 | Blood pressure, BP, pulse | VASCU000010 | 20.61 | Vascular | Stromal / connective | 1,008 | 5 | 7 | 16 | |
| 97 | DLK1/PIK3IP1 ratio | PRORT000912 | 20.54 | Protein ratios | Stromal / connective | 1 | 4 | 10 | 35 | |
| 98 | EGFR levels | PROLV000687 | 20.27 | Protein levels | Adipose | 22 | 3 | 10 | 13 | |
| 99 | SCARA5 levels | PROLV001780 | 20.23 | Protein levels | Stromal / connective | 8 | 2 | 4 | 9 | |
| 100 | CD79B/FCRL2 ratio | PRORT000511 | 20.21 | Protein ratios | Stromal / connective | 17 | 2 | 7 | 12 | |
| 101 | BCL2 levels | PROLV000185 | 20.00 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 102 | ADGRD1 levels | PROLV000041 | 19.88 | Protein levels | Hepatocyte | 47 | 5 | 12 | 15 | |
| 103 | F7/VASN ratio | PRORT001089 | 19.83 | Protein ratios | Hepatocyte | 19 | 1 | 9 | 12 | |
| 104 | AHCY/HSPA1A ratio | PRORT000055 | 19.74 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 105 | Haemorrhoidal disease | VASCU000062 | 19.73 | Vascular | Vascular | 67 | 4 | 9 | 16 | |
| 106 | Cardiac angiography | CARDI000047 | 19.56 | Cardiac | Stromal / connective | 14 | 3 | 8 | 17 | |
| 107 | Osteoporosis | MSKEL000010 | 19.54 | Musculoskeletal | Stromal / connective | 5 | 3 | 5 | 21 | |
| 108 | Heme malignancy, Lymphoma | MALIG000044 | 19.52 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 109 | CCN3/FAP ratio | PRORT000373 | 19.36 | Protein ratios | Hepatocyte | 27 | 4 | 11 | 24 | |
| 110 | Medication, angiotensin receptor blocker | VASCU000029 | 19.36 | Vascular | Adipose | 0 | 1 | 8 | 19 | |
| 111 | Fasciitis | MSKEL000063 | 19.32 | Musculoskeletal | Stromal / connective | 16 | 1 | 3 | 8 | |
| 112 | FAP/LRRN1 ratio | PRORT001116 | 19.28 | Protein ratios | Muscle / cardiac | 42 | 5 | 15 | 34 | |
| 113 | DAB2/TBL1X ratio | PRORT000841 | 19.27 | Protein ratios | Granulosa cell | 1 | 5 | 12 | 35 | |
| 114 | SFRP2 levels | PROLV001845 | 19.18 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 115 | DPP6/SEZ6L ratio | PRORT000947 | 19.12 | Protein ratios | Adipose | 8 | 3 | 10 | 14 | |
| 116 | Blood pressure, BP, diastolic x sex interaction | VASCU000008 | 19.07 | Vascular | Muscle / cardiac | 0 | 2 | 12 | 23 | |
| 117 | CA2/HMBS ratio | PRORT000275 | 18.96 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 118 | PLXDC1 levels | PROLV001583 | 18.90 | Protein levels | Adipose | 4 | 2 | 13 | 38 | |
| 119 | Carpal tunnel surgery | MSKEL000044 | 18.80 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 120 | Medication, anti-malarial | IMMUN000083 | 18.76 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 121 | FST/FSTL3 ratio | PRORT001180 | 18.72 | Protein ratios | Stromal / connective | 0 | 4 | 15 | 20 | |
| 122 | ADGRB3 levels | PROLV000040 | 18.66 | Protein levels | Stromal / connective | 34 | 5 | 8 | 25 | |
| 123 | ISLR2 levels | PROLV001101 | 18.64 | Protein levels | Granulosa cell | 65 | 4 | 11 | 16 | |
| 124 | CD109 levels | PROLV000309 | 18.63 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 125 | FCRL2/TNFRSF13B ratio | PRORT001132 | 18.62 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 126 | Knee extension strength | MSKEL000031 | 18.48 | Musculoskeletal | Stromal / connective | 0 | 2 | 6 | 10 | |
| 127 | Glutamate metabolites | METAB000005 | 18.47 | Metabolites | Vascular | 0 | 0 | 2 | 5 | |
| 128 | ESR1 levels | PROLV000735 | 18.43 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 129 | RGMB/SMOC2 ratio | PRORT001737 | 18.35 | Protein ratios | Myeloid | 30 | 4 | 10 | 19 | |
| 130 | PLXDC2 levels | PROLV001584 | 18.01 | Protein levels | Granulosa cell | 18 | 4 | 16 | 23 | |
| 131 | APOF levels | PROLV000125 | 17.96 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 132 | BTN2A1/SMOC2 ratio | PRORT000260 | 17.82 | Protein ratios | Myeloid | 49 | 4 | 8 | 21 | |
| 133 | PAMR1 levels | PROLV001493 | 17.79 | Protein levels | Myeloid | 137 | 3 | 13 | 23 | |
| 134 | ADAMTS8 levels | PROLV000035 | 17.54 | Protein levels | Muscle / cardiac | 48 | 3 | 5 | 11 | |
| 135 | COMP/DPP4 ratio | PRORT000709 | 17.53 | Protein ratios | Myeloid | 32 | 4 | 13 | 18 | |
| 136 | ATXN2L levels | PROLV000165 | 17.14 | Protein levels | Stromal / connective | 0 | 1 | 6 | 16 | |
| 137 | UNC5D levels | PROLV002141 | 17.11 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 138 | ALKBH3 levels | PROLV000080 | 16.87 | Protein levels | Myeloid | 0 | 4 | 14 | 18 | |
| 139 | MAMDC2 levels | PROLV001258 | 16.75 | Protein levels | Stromal / connective | 36 | 5 | 8 | 14 | |
| 140 | IFIT2 levels | PROLV001016 | 16.71 | Protein levels | Myeloid | 17 | 5 | 9 | 20 | |
| 141 | C7 levels | PROLV000236 | 16.68 | Protein levels | Adipose | 12 | 2 | 11 | 27 | |
| 142 | CNTN5 levels | PROLV000479 | 16.58 | Protein levels | Myeloid | 1 | 4 | 6 | 13 | |
| 143 | Medication, macular degeneration | OPHTH000015 | 16.44 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 144 | COMP/MYOC ratio | PRORT000712 | 16.36 | Protein ratios | Adipose | 3 | 4 | 14 | 23 | |
| 145 | SNX9/STIP1 ratio | PRORT001801 | 16.32 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 146 | FGF19 levels | PROLV000793 | 16.23 | Protein levels | Hepatocyte | 49 | 1 | 7 | 22 | |
| 147 | ASPN levels | PROLV000153 | 16.14 | Protein levels | Stromal / connective | 10 | 4 | 12 | 35 | |
| 148 | RBP7 levels | PROLV001713 | 16.03 | Protein levels | Neural / glial | 36 | 3 | 9 | 11 | |
| 149 | HSPG2/VASN ratio | PRORT001310 | 16.00 | Protein ratios | Vascular | 16 | 4 | 7 | 21 | |
| 150 | BSG/LAMP3 ratio | PRORT000248 | 15.94 | Protein ratios | Myeloid | 33 | 1 | 8 | 14 | |
| 151 | Glaucoma | OPHTH000009 | 15.84 | Ophthalmic | Stromal / connective | 407 | 3 | 7 | 9 | |
| 152 | CHRDL1/SMOC2 ratio | PRORT000614 | 15.82 | Protein ratios | Adipose | 3 | 3 | 7 | 14 | |
| 153 | Dorsopathy | MSKEL000075 | 15.77 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 154 | PRTG levels | PROLV001650 | 15.64 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 155 | ADGRG2 levels | PROLV000047 | 15.59 | Protein levels | Myeloid | 24 | 2 | 8 | 15 | |
| 156 | PPP2R2A levels | PROLV001618 | 15.52 | Protein levels | Lymphocyte | 0 | 3 | 9 | 29 | |
| 157 | COL6A3/HSPG2 ratio | PRORT000697 | 15.51 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 158 | TNFRSF4/TNFRSF9 ratio | PRORT001854 | 15.45 | Protein ratios | Stromal / connective | 5 | 2 | 8 | 18 | |
| 159 | THBS2 levels | PROLV002026 | 15.34 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 160 | GRAP2/SNX9 ratio | PRORT001245 | 15.34 | Protein ratios | Hepatocyte | 6 | 4 | 7 | 27 | |
| 161 | Wisdom tooth surgery | DENTA000005 | 15.18 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 162 | Eyelid disorder | OPHTH000019 | 15.13 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 163 | HSPG2 levels | PROLV000999 | 14.82 | Protein levels | Adipose | 16 | 2 | 5 | 13 | |
| 164 | SFRP4 levels | PROLV001846 | 14.81 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 165 | ENPP7 levels | PROLV000711 | 14.73 | Protein levels | Hepatocyte | 60 | 2 | 10 | 22 | |
| 166 | Fatty acids, undecenoic acid | LIPID000030 | 14.73 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 167 | PRELP levels | PROLV001627 | 14.72 | Protein levels | Stromal / connective | 71 | 4 | 9 | 11 | |
| 168 | INHBC levels | PROLV001088 | 14.70 | Protein levels | Hepatocyte | 91 | 2 | 8 | 18 | |
| 169 | Intracranial volume | NIMAG000025 | 14.58 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 170 | EFNA1/PIK3IP1 ratio | PRORT000989 | 14.58 | Protein ratios | Hepatocyte | 29 | 2 | 10 | 21 | |
| 171 | Atrial volume | CARDI000009 | 14.52 | Cardiac | Stromal / connective | 0 | 3 | 9 | 19 | |
| 172 | FURIN/PLA2G15 ratio | PRORT001185 | 14.48 | Protein ratios | Adipose | 9 | 2 | 8 | 18 | |
| 173 | CALCA levels | PROLV000255 | 14.48 | Protein levels | Stromal / connective | 6 | 4 | 7 | 22 | |
| 174 | Phenylalanine | METAB000027 | 14.45 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 175 | FGF19/SCG2 ratio | PRORT001139 | 14.43 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 13 | |
| 176 | BPIFB1/GLRX ratio | PRORT000245 | 14.32 | Protein ratios | Adipose | 0 | 4 | 9 | 18 | |
| 177 | FAM3B/FGF19 ratio | PRORT001111 | 14.22 | Protein ratios | Hepatocyte | 18 | 2 | 7 | 14 | |
| 178 | Immune cell marker, CD8 T cell | HEMAT000023 | 14.15 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 179 | HAMP levels | PROLV000950 | 14.11 | Protein levels | Vascular | 8 | 5 | 10 | 10 | |
| 180 | SIL1 levels | PROLV001866 | 14.04 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 181 | CREG1/NAAA ratio | PRORT000752 | 13.93 | Protein ratios | Granulosa cell | 9 | 3 | 11 | 23 | |
| 182 | LAMP1 levels | PROLV001180 | 13.91 | Protein levels | Myeloid | 47 | 3 | 9 | 19 | |
| 183 | Bone infection | IMMUN000053 | 13.89 | Immunologic | Myeloid | 0 | 3 | 10 | 24 | |
| 184 | AIFM1/EGF ratio | PRORT000059 | 13.81 | Protein ratios | Hepatocyte | 15 | 2 | 10 | 20 | |
| 185 | DLK1 levels | PROLV000625 | 13.74 | Protein levels | Muscle / cardiac | 29 | 4 | 9 | 25 | |
| 186 | TMSB10/ZBTB16 ratio | PRORT001842 | 13.73 | Protein ratios | Muscle / cardiac | 29 | 4 | 8 | 25 | |
| 187 | Osteopenia | MSKEL000009 | 13.68 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 188 | Lens replacement | OPHTH000025 | 13.66 | Ophthalmic | Vascular | 12 | 2 | 13 | 17 | |
| 189 | Digital deformity | MSKEL000053 | 13.61 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 190 | F7/PROC ratio | PRORT001088 | 13.57 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 12 | |
| 191 | SNX5 levels | PROLV001914 | 13.53 | Protein levels | Myeloid | 6 | 3 | 11 | 24 | |
| 192 | NRP1 levels | PROLV001434 | 13.51 | Protein levels | Hepatocyte | 128 | 2 | 10 | 21 | |
| 193 | COL24A1 levels | PROLV000486 | 13.42 | Protein levels | Stromal / connective | 2 | 5 | 10 | 25 | |
| 194 | IL31RA levels | PROLV001071 | 13.35 | Protein levels | Granulosa cell | 1 | 3 | 7 | 13 | |
| 195 | CASP1 levels | PROLV000265 | 13.34 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 196 | Thigh muscle volume | BMORP000020 | 13.28 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 197 | GLA levels | PROLV000893 | 13.16 | Protein levels | Lymphocyte | 2 | 3 | 6 | 30 | |
| 198 | Mental disorder | PSYCH000013 | 13.06 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 199 | Fracture | MSKEL000011 | 12.98 | Musculoskeletal | Stromal / connective | 27 | 1 | 1 | 1 | |
| 200 | Hydrocele | REPRO000012 | 12.95 | Reproductive | Stromal / connective | 7 | 0 | 8 | 15 | |
| 201 | Aortic diameter | VASCU000052 | 12.93 | Vascular | Muscle / cardiac | 215 | 5 | 7 | 19 | |
| 202 | Serine | METAB000029 | 12.91 | Metabolites | Epithelial | 1 | 4 | 13 | 17 | |
| 203 | Testicular disorder | REPRO000015 | 12.74 | Reproductive | Adipose | 8 | 1 | 8 | 13 | |
| 204 | Coronary artery calcification | VASCU000055 | 12.65 | Vascular | Vascular | 56 | 4 | 6 | 11 | |
| 205 | SRPX levels | PROLV001945 | 12.62 | Protein levels | Adipose | 32 | 4 | 10 | 16 | |
| 206 | MSMB levels | PROLV001341 | 12.59 | Protein levels | Stromal / connective | 32 | 3 | 9 | 14 | |
| 207 | DPP4 levels | PROLV000646 | 12.58 | Protein levels | Myeloid | 44 | 3 | 12 | 22 | |
| 208 | Female genital disorder | REPRO000006 | 12.52 | Reproductive | Stromal / connective | 14 | 4 | 9 | 13 | |
| 209 | Mammary dysplasia | BREAS000001 | 12.33 | Breast | Adipose | 0 | 1 | 8 | 17 | |
| 210 | COL6A3/OGN ratio | PRORT000699 | 12.33 | Protein ratios | Adipose | 33 | 5 | 8 | 16 | |
| 211 | OLR1 levels | PROLV001467 | 12.33 | Protein levels | Myeloid | 37 | 2 | 7 | 17 | |
| 212 | FURIN/IGSF3 ratio | PRORT001183 | 12.32 | Protein ratios | Hepatocyte | 11 | 1 | 8 | 15 | |
| 213 | Physical function | MISCL000041 | 12.20 | Miscellaneous | Stromal / connective | 502 | 3 | 4 | 9 | |
| 214 | Forced expiratory volume, FEV | RESPI000019 | 12.08 | Respiratory | Stromal / connective | 370 | 1 | 5 | 13 | |
| 215 | PSAP levels | PROLV001653 | 12.08 | Protein levels | Myeloid | 52 | 2 | 7 | 16 | |
| 216 | CD40LG/SERPINE1 ratio | PRORT000453 | 12.03 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 217 | Urinary metabolite ratio | METAB000057 | 11.96 | Metabolites | Hepatocyte | 1 | 1 | 4 | 17 | |
| 218 | LGALS3 levels | PROLV001202 | 11.89 | Protein levels | Vascular | 28 | 1 | 2 | 8 | |
| 219 | MFAP4 levels | PROLV001305 | 11.88 | Protein levels | Myeloid | 75 | 4 | 9 | 20 | |
| 220 | CSF unidentified metabolite | METAB000075 | 11.88 | Metabolites | Muscle / cardiac | 1 | 0 | 2 | 3 | |
| 221 | CST3/TFF3 ratio | PRORT000788 | 11.74 | Protein ratios | Adipose | 7 | 1 | 9 | 12 | |
| 222 | IL13RA1 levels | PROLV001047 | 11.68 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 223 | GGH/INHBC ratio | PRORT001212 | 11.64 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 25 | |
| 224 | ST6GALNAC2 levels | PROLV001954 | 11.63 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 225 | PRKAR1A/SNAP23 ratio | PRORT001710 | 11.59 | Protein ratios | Hepatocyte | 4 | 3 | 18 | 38 | |
| 226 | CPQ levels | PROLV000509 | 11.54 | Protein levels | Epithelial | 108 | 2 | 7 | 18 | |
| 227 | CXCL10/WARS ratio | PRORT000815 | 11.34 | Protein ratios | Hepatocyte | 4 | 2 | 9 | 17 | |
| 228 | Nucleoside metabolites | METAB000061 | 11.31 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 229 | Spinal stenosis | MSKEL000078 | 11.29 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 230 | Alanine metabolite | METAB000001 | 11.27 | Metabolites | Gastrointestinal epithelium | 0 | 2 | 9 | 7 | |
| 231 | Kidney transplant | NEPHR000023 | 11.21 | Nephrourologic | Muscle / cardiac | 0 | 1 | 12 | 19 | |
| 232 | ADGRE2/B4GALT1 ratio | PRORT000027 | 11.20 | Protein ratios | Myeloid | 57 | 3 | 11 | 23 | |
| 233 | AARSD1/UBAC1 ratio | PRORT000002 | 11.19 | Protein ratios | Muscle / cardiac | 0 | 3 | 6 | 13 | |
| 234 | IGFBP6/PTGDS ratio | PRORT001337 | 11.15 | Protein ratios | Myeloid | 19 | 2 | 7 | 18 | |
| 235 | FUT8/TNFSF14 ratio | PRORT001192 | 11.13 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 236 | CPM levels | PROLV000507 | 11.06 | Protein levels | Myeloid | 138 | 3 | 11 | 11 | |
| 237 | ITGAV levels | PROLV001110 | 11.01 | Protein levels | Hepatocyte | 116 | 4 | 14 | 24 | |
| 238 | Retinal and choroidal disorder | OPHTH000038 | 10.96 | Ophthalmic | Stromal / connective | 74 | 4 | 9 | 18 | |
| 239 | CTSZ/NAAA ratio | PRORT000805 | 10.96 | Protein ratios | Stromal / connective | 45 | 2 | 10 | 14 | |
| 240 | Brain neuroimaging feature | NIMAG000005 | 10.94 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 241 | FAP/THBS4 ratio | PRORT001117 | 10.91 | Protein ratios | Hepatocyte | 21 | 4 | 12 | 33 | |
| 242 | Female genital tract polyp | REPRO000009 | 10.89 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 243 | DSG4 levels | PROLV000657 | 10.88 | Protein levels | Cutaneous epithelium | 24 | 1 | 7 | 10 | |
| 244 | CD27/FCRL5 ratio | PRORT000413 | 10.83 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 245 | NAAA/SMPD1 ratio | PRORT001569 | 10.81 | Protein ratios | Granulosa cell | 6 | 3 | 12 | 20 | |
| 246 | DNAJA2/PLXNA4 ratio | PRORT000923 | 10.81 | Protein ratios | Lymphocyte | 20 | 6 | 17 | 40 | |
| 247 | PTPRZ1 levels | PROLV001682 | 10.79 | Protein levels | Myeloid | 82 | 3 | 10 | 17 | |
| 248 | COLEC12/OGN ratio | PRORT000705 | 10.73 | Protein ratios | Stromal / connective | 12 | 3 | 11 | 19 | |
| 249 | Gout | METBL000043 | 10.72 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 250 | CR2 levels | PROLV000514 | 10.56 | Protein levels | B / plasma cell | 95 | 3 | 9 | 11 | |
| 251 | ERBB3 levels | PROLV000725 | 10.55 | Protein levels | Hepatocyte | 97 | 4 | 10 | 20 | |
| 252 | Low hand grip strength | MSKEL000032 | 10.47 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 253 | GAPDH levels | PROLV000853 | 10.47 | Protein levels | Muscle / cardiac | 0 | 3 | 9 | 33 | |
| 254 | PFDN5 levels | PROLV001539 | 10.42 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 255 | Consultant specialty, ophthalmology | MISCL000018 | 10.42 | Miscellaneous | Vascular | 0 | 4 | 12 | 22 | |
| 256 | MATN2/SCARA5 ratio | PRORT001494 | 10.36 | Protein ratios | Stromal / connective | 12 | 5 | 9 | 19 | |
| 257 | SERPINA3 levels | PROLV001817 | 10.34 | Protein levels | Myeloid | 2 | 3 | 8 | 14 | |
| 258 | Aortic aneurysm | VASCU000002 | 10.28 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 259 | Medication, antithrombotic | VASCU000033 | 10.23 | Vascular | Vascular | 37 | 4 | 10 | 12 | |
| 260 | DCBLD2 levels | PROLV000600 | 10.17 | Protein levels | Hepatocyte | 264 | 3 | 13 | 20 | |
| 261 | HMCN2 levels | PROLV000977 | 10.13 | Protein levels | Stromal / connective | 14 | 5 | 10 | 18 | |
| 262 | NPL levels | PROLV001423 | 10.13 | Protein levels | Myeloid | 36 | 4 | 8 | 19 | |
| 263 | OLR1/PLAUR ratio | PRORT001613 | 10.09 | Protein ratios | Myeloid | 36 | 3 | 7 | 11 | |
| 264 | ITGA11 levels | PROLV001104 | 10.06 | Protein levels | Hepatocyte | 66 | 3 | 11 | 20 | |
| 265 | Alzheimer disease | NEURO000018 | 10.05 | Neurologic | Myeloid | 182 | 2 | 8 | 9 | |
| 266 | Tuberculosis, TB | IMMUN000050 | 10.05 | Immunologic | Muscle / cardiac | — | 3 | 8 | 12 | |
| 267 | Xenobiotic metabolites | METAB000080 | 10.05 | Metabolites | Hepatocyte | 26 | 1 | 3 | 11 | |
| 268 | LRRN1 levels | PROLV001236 | 10.00 | Protein levels | Muscle / cardiac | 81 | 3 | 8 | 25 | |
| 269 | POSTN levels | PROLV001603 | 9.98 | Protein levels | Adipose | 40 | 1 | 5 | 14 | |
| 270 | CAPG levels | PROLV000262 | 9.96 | Protein levels | Lymphocyte | 34 | 3 | 16 | 42 | |
| 271 | PSME2/RBKS ratio | PRORT001713 | 9.91 | Protein ratios | Hepatocyte | 23 | 4 | 15 | 13 | |
| 272 | Latent factor, red cell | HEMAT000038 | 9.88 | Hematologic | Lymphocyte | 67 | 0 | 1 | 4 | |
| 273 | MXRA8 levels | PROLV001355 | 9.87 | Protein levels | Myeloid | 78 | 5 | 12 | 24 | |
| 274 | CR2/TNFRSF13B ratio | PRORT000738 | 9.76 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 275 | Peripheral nerve disorder | NEURO000031 | 9.73 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 276 | SCARF2 levels | PROLV001783 | 9.73 | Protein levels | Adipose | 49 | 2 | 6 | 11 | |
| 277 | Arterial dissection | VASCU000003 | 9.73 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 278 | TMSB10/TRIAP1 ratio | PRORT001840 | 9.68 | Protein ratios | Myeloid | 2 | 3 | 7 | 14 | |
| 279 | FABP5 levels | PROLV000755 | 9.58 | Protein levels | Stromal / connective | 7 | 5 | 11 | 35 | |
| 280 | Mononeuropathy | NEURO000027 | 9.58 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 281 | CD70 levels | PROLV000353 | 9.56 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 282 | DKKL1 levels | PROLV000623 | 9.52 | Protein levels | Hepatocyte | 77 | 4 | 10 | 25 | |
| 283 | Fatty acids metabolites | METAB000052 | 9.47 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 284 | CLUL1 levels | PROLV000468 | 9.43 | Protein levels | Hepatocyte | 71 | 4 | 9 | 27 | |
| 285 | COL3A1 levels | PROLV000489 | 9.41 | Protein levels | Myeloid | 15 | 4 | 10 | 22 | |
| 286 | HGF/TNFSF14 ratio | PRORT001286 | 9.41 | Protein ratios | Hepatocyte | 19 | 5 | 14 | 27 | |
| 287 | SCAMP3/VPS53 ratio | PRORT001757 | 9.30 | Protein ratios | Vascular | 0 | 2 | 9 | 19 | |
| 288 | Heart rate variability | CARDI000022 | 9.30 | Cardiac | Muscle / cardiac | 10 | 2 | 4 | 15 | |
| 289 | AIFM1/PLXNA4 ratio | PRORT000060 | 9.27 | Protein ratios | Hepatocyte | 9 | 2 | 10 | 26 | |
| 290 | HJV levels | PROLV000971 | 9.25 | Protein levels | Hepatocyte | 12 | 4 | 12 | 35 | |
| 291 | CHCHD10 levels | PROLV000424 | 9.17 | Protein levels | Muscle / cardiac | 0 | 4 | 8 | 21 | |
| 292 | Knee morphology | MSKEL000024 | 9.16 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 293 | DPP6 levels | PROLV000647 | 9.10 | Protein levels | Myeloid | 131 | 3 | 11 | 15 | |
| 294 | MAVS/PPP1R9B ratio | PRORT001498 | 9.08 | Protein ratios | Adipose | 0 | 3 | 12 | 33 | |
| 295 | CD59/SCARB2 ratio | PRORT000483 | 9.02 | Protein ratios | Myeloid | 16 | 4 | 10 | 20 | |
| 296 | SMOC2 levels | PROLV001900 | 9.01 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 297 | FCRL2/SEMA7A ratio | PRORT001131 | 8.98 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 298 | Brain neuroimaging quality metric | NIMAG000006 | 8.97 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 299 | CCDC80 levels | PROLV000276 | 8.93 | Protein levels | Myeloid | 30 | 2 | 6 | 14 | |
| 300 | ALCAM/ENPP2 ratio | PRORT000070 | 8.87 | Protein ratios | Hepatocyte | 51 | 3 | 12 | 18 | |
| 301 | CTSC/PLA2G15 ratio | PRORT000798 | 8.75 | Protein ratios | Hepatocyte | 20 | 1 | 10 | 34 | |
| 302 | ADAM9 levels | PROLV000030 | 8.74 | Protein levels | Myeloid | 119 | 3 | 12 | 18 | |
| 303 | Aneurysm | VASCU000001 | 8.69 | Vascular | Hepatocyte | 141 | 4 | 8 | 22 | |
| 304 | CCL17/CD69 ratio | PRORT000343 | 8.64 | Protein ratios | Myeloid | 13 | 4 | 18 | 47 | |
| 305 | Medication, proton pump inhibitor | GASTR000017 | 8.52 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 306 | CHCHD6 levels | PROLV000425 | 8.50 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 307 | ATXN10/SLC27A4 ratio | PRORT000163 | 8.49 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 308 | GPNMB levels | PROLV000927 | 8.48 | Protein levels | Hepatocyte | 49 | 5 | 9 | 24 | |
| 309 | CES1 levels | PROLV000405 | 8.44 | Protein levels | Hepatocyte | 148 | 1 | 8 | 13 | |
| 310 | Operation, vascular | VASCU000058 | 8.40 | Vascular | Vascular | 116 | 4 | 7 | 10 | |
| 311 | Tyrosine metabolites | METAB000016 | 8.39 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 312 | MEGF9 levels | PROLV001294 | 8.38 | Protein levels | Hepatocyte | 93 | 2 | 11 | 23 | |
| 313 | ASGR1/GGT5 ratio | PRORT000148 | 8.35 | Protein ratios | Hepatocyte | 60 | 1 | 9 | 18 | |
| 314 | BAMBI levels | PROLV000177 | 8.30 | Protein levels | Stromal / connective | 10 | 0 | 1 | 10 | |
| 315 | White matter lesion volume | NIMAG000027 | 8.29 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 316 | COMP levels | PROLV000496 | 8.28 | Protein levels | Myeloid | 133 | 3 | 11 | 17 | |
| 317 | CA11 levels | PROLV000240 | 8.24 | Protein levels | Adipose | 0 | 3 | 6 | 23 | |
| 318 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 8.23 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 319 | NXPH3 levels | PROLV001458 | 8.22 | Protein levels | Stromal / connective | 3 | 1 | 4 | 15 | |
| 320 | Headache | NEURO000009 | 8.18 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 321 | FABP2/RBP2 ratio | PRORT001099 | 8.16 | Protein ratios | Neural / glial | 2 | 4 | 14 | 20 | |
| 322 | NCAM2 levels | PROLV001378 | 8.11 | Protein levels | Myeloid | 33 | 3 | 7 | 17 | |
| 323 | ADGRE5/VCAM1 ratio | PRORT000034 | 8.10 | Protein ratios | Myeloid | 37 | 4 | 11 | 18 | |
| 324 | Nerve root disorder | NEURO000030 | 8.08 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 325 | MYOC levels | PROLV001363 | 8.08 | Protein levels | Vascular | 33 | 0 | 5 | 12 | |
| 326 | PGR levels | PROLV001548 | 8.02 | Protein levels | B / plasma cell | 21 | 3 | 12 | 30 | |
| 327 | AZU1/MPO ratio | PRORT000185 | 8.01 | Protein ratios | Myeloid | 8 | 1 | 4 | 8 | |
| 328 | Menopausal disorder | REPRO000020 | 7.98 | Reproductive | Hepatocyte | 0 | 5 | 9 | 25 | |
| 329 | ANGPTL2 levels | PROLV000096 | 7.97 | Protein levels | Stromal / connective | 48 | 3 | 17 | 12 | |
| 330 | FCRL2/LY9 ratio | PRORT001130 | 7.94 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 331 | MESD/NCK2 ratio | PRORT001516 | 7.93 | Protein ratios | Neural / glial | 8 | 4 | 10 | 17 | |
| 332 | Alport syndrome | NEPHR000003 | 7.93 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 333 | ITGBL1 levels | PROLV001117 | 7.93 | Protein levels | Vascular | 82 | 3 | 11 | 14 | |
| 334 | Visual impairment | OPHTH000046 | 7.92 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 335 | GLB1/IMPA1 ratio | PRORT001216 | 7.90 | Protein ratios | Myeloid | 65 | 4 | 11 | 19 | |
| 336 | SPTLC1 levels | PROLV001941 | 7.83 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 337 | CD55 levels | PROLV000345 | 7.79 | Protein levels | Adipose | 54 | 0 | 9 | 16 | |
| 338 | CCN1/DNAJB1 ratio | PRORT000361 | 7.76 | Protein ratios | Hepatocyte | 26 | 4 | 14 | 37 | |
| 339 | Lens disorder | OPHTH000013 | 7.75 | Ophthalmic | Stromal / connective | 3 | 5 | 8 | 10 | |
| 340 | CLK2 levels | PROLV000460 | 7.72 | Protein levels | Hepatocyte | 11 | 2 | 7 | 20 | |
| 341 | VIT levels | PROLV002162 | 7.70 | Protein levels | Myeloid | 11 | 6 | 14 | 27 | |
| 342 | Cancer, Pancreas | MALIG000025 | 7.65 | Malignancy | Myeloid | 0 | 0 | 5 | 4 | |
| 343 | TSTA3 levels | PROLV002118 | 7.63 | Protein levels | Vascular | 10 | 3 | 7 | 12 | |
| 344 | NTRK2 levels | PROLV001447 | 7.62 | Protein levels | Myeloid | 73 | 3 | 11 | 21 | |
| 345 | MCEE levels | PROLV001284 | 7.62 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 346 | Gynaecomastia | BREAS000003 | 7.59 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 347 | CCN3 levels | PROLV000303 | 7.59 | Protein levels | Vascular | 8 | 1 | 4 | 10 | |
| 348 | Ocular refraction | OPHTH000033 | 7.58 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 349 | Sulcal opening distance | NIMAG000012 | 7.57 | Neuroimaging | Vascular | 11 | 5 | 9 | 18 | |
| 350 | SERPING1 levels | PROLV001834 | 7.54 | Protein levels | Myeloid | 141 | 3 | 12 | 23 | |
| 351 | APP/FKBP1B ratio | PRORT000125 | 7.53 | Protein ratios | Myeloid | 0 | 4 | 15 | 21 | |
| 352 | NTPROBNP levels | PROLV001446 | 7.48 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 353 | Macular degeneration | OPHTH000036 | 7.44 | Ophthalmic | Hepatocyte | 106 | 2 | 7 | 15 | |
| 354 | B4GALT1/SMOC2 ratio | PRORT000189 | 7.42 | Protein ratios | Myeloid | 7 | 2 | 6 | 18 | |
| 355 | GGCT levels | PROLV000881 | 7.36 | Protein levels | Lymphocyte | 3 | 4 | 9 | 32 | |
| 356 | DNAJA2/HPCAL1 ratio | PRORT000922 | 7.34 | Protein ratios | Myeloid | 2 | 5 | 16 | 37 | |
| 357 | NPY/SMOC1 ratio | PRORT001596 | 7.33 | Protein ratios | Hepatocyte | 49 | 2 | 8 | 14 | |
| 358 | AGRN/HSPG2 ratio | PRORT000048 | 7.28 | Protein ratios | Stromal / connective | 22 | 7 | 7 | 25 | |
| 359 | PPT1 levels | PROLV001621 | 7.25 | Protein levels | Melanocyte | 2 | 3 | 7 | 26 | |
| 360 | Ocular alignment procedures | OPHTH000026 | 7.24 | Ophthalmic | Neural / glial | 1 | 2 | 5 | 18 | |
| 361 | LILRB4 levels | PROLV001215 | 7.19 | Protein levels | Myeloid | 162 | 2 | 8 | 19 | |
| 362 | CA2/PSMG3 ratio | PRORT000277 | 7.19 | Protein ratios | Lymphocyte | 3 | 3 | 4 | 19 | |
| 363 | PKD1 levels | PROLV001564 | 7.15 | Protein levels | Vascular | 84 | 4 | 11 | 19 | |
| 364 | CD276 levels | PROLV000326 | 7.14 | Protein levels | Adipose | 14 | 0 | 4 | 4 | |
| 365 | GSTA4 levels | PROLV000941 | 7.12 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 366 | CLEC14A/PIK3IP1 ratio | PRORT000627 | 7.12 | Protein ratios | Vascular | 6 | 2 | 9 | 14 | |
| 367 | Trunk mass | BCOMP000019 | 7.08 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 368 | Ganglion cyst | MSKEL000065 | 7.07 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 369 | Brain ventricle volume | NIMAG000016 | 7.07 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 370 | PARK7/TNFRSF9 ratio | PRORT001621 | 7.06 | Protein ratios | Neural / glial | 8 | 3 | 6 | 18 | |
| 371 | DDR1 levels | PROLV000610 | 7.06 | Protein levels | Melanocyte | 92 | 3 | 14 | 23 | |
| 372 | VWF levels | PROLV002182 | 7.03 | Protein levels | Vascular | 12 | 2 | 5 | 13 | |
| 373 | FST levels | PROLV000829 | 7.03 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 374 | PAPL levels | PROLV001494 | 7.01 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 375 | APOH levels | PROLV000126 | 6.99 | Protein levels | Hepatocyte | 2 | 2 | 10 | 17 | |
| 376 | Hypertension, secondary | VASCU000026 | 6.98 | Vascular | Renal epithelium | — | 0 | 17 | 26 | |
| 377 | Osteomyelitis | IMMUN000068 | 6.94 | Immunologic | Stromal / connective | 19 | 2 | 4 | 5 | |
| 378 | VNN1 levels | PROLV002164 | 6.90 | Protein levels | Hepatocyte | 55 | 3 | 12 | 25 | |
| 379 | CNTN3 levels | PROLV000477 | 6.89 | Protein levels | Hepatocyte | 99 | 4 | 9 | 30 | |
| 380 | APOM/MCAM ratio | PRORT000119 | 6.88 | Protein ratios | Hepatocyte | 64 | 2 | 10 | 18 | |
| 381 | KIAA0040 levels | PROLV001136 | 6.88 | Protein levels | Stromal / connective | 0 | 2 | 8 | 14 | |
| 382 | CIAPIN1/SNX9 ratio | PRORT000617 | 6.87 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 383 | ANPEP/DPP4 ratio | PRORT000101 | 6.85 | Protein ratios | Hepatocyte | 25 | 3 | 11 | 18 | |
| 384 | PLAUR/TREM2 ratio | PRORT001680 | 6.80 | Protein ratios | Hepatocyte | 73 | 3 | 12 | 16 | |
| 385 | Retinal detachments and defects | OPHTH000039 | 6.79 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 386 | COL18A1 levels | PROLV000484 | 6.77 | Protein levels | Stromal / connective | 55 | 3 | 7 | 12 | |
| 387 | Rotator cuff injury | MSKEL000067 | 6.77 | Musculoskeletal | Stromal / connective | 0 | 3 | 7 | 17 | |
| 388 | Optic disc morphology | OPHTH000030 | 6.75 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 389 | PLA2G15/PRCP ratio | PRORT001670 | 6.73 | Protein ratios | Myeloid | 44 | 3 | 11 | 21 | |
| 390 | Frailty, metabolic problems | METBL000011 | 6.73 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 391 | ANGPTL7 levels | PROLV000099 | 6.72 | Protein levels | Stromal / connective | 32 | 2 | 9 | 13 | |
| 392 | Aortic valve disease | CARDI000053 | 6.71 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 393 | Intervertebral disc disorder | MSKEL000076 | 6.70 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 394 | PER3 levels | PROLV001537 | 6.68 | Protein levels | Muscle / cardiac | 5 | 3 | 10 | 17 | |
| 395 | Peripheral neuropathy | NEURO000032 | 6.67 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 396 | Kidney failure, acute | NEPHR000012 | 6.63 | Nephrourologic | Lymphocyte | 0 | 2 | 15 | 24 | |
| 397 | Synovium, tendon and bursa disorder | MSKEL000057 | 6.61 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 398 | NCAM1 levels | PROLV001377 | 6.60 | Protein levels | Muscle / cardiac | 119 | 4 | 11 | 24 | |
| 399 | Jaw relationship anomaly | DENTA000007 | 6.57 | Dental | Neural / glial | 0 | 1 | 5 | 12 | |
| 400 | Benign neoplasm, Adipose | MALIG000001 | 6.56 | Malignancy | Adipose | 1 | 2 | 6 | 14 | |
| 401 | VSNL1 levels | PROLV002173 | 6.55 | Protein levels | Myeloid | 44 | 2 | 9 | 20 | |
| 402 | ASGR1 levels | PROLV000151 | 6.55 | Protein levels | Hepatocyte | 61 | 5 | 15 | 29 | |
| 403 | CA5A/KRT18 ratio | PRORT000288 | 6.53 | Protein ratios | Hepatocyte | 18 | 1 | 10 | 19 | |
| 404 | CD74/LILRB4 ratio | PRORT000505 | 6.52 | Protein ratios | Vascular | 42 | 4 | 9 | 21 | |
| 405 | LEPR levels | PROLV001200 | 6.51 | Protein levels | Myeloid | 79 | 3 | 10 | 26 | |
| 406 | RBP5 levels | PROLV001712 | 6.51 | Protein levels | Adipose | 3 | 0 | 8 | 32 | |
| 407 | CCN3/COL6A3 ratio | PRORT000372 | 6.51 | Protein ratios | Stromal / connective | 26 | 0 | 3 | 5 | |
| 408 | TNN levels | PROLV002083 | 6.51 | Protein levels | Stromal / connective | 16 | 2 | 9 | 11 | |
| 409 | Male-pattern baldness | DERMA000032 | 6.49 | Dermatologic | Stromal / connective | 74 | 0 | 4 | 6 | |
| 410 | CA1/HMBS ratio | PRORT000269 | 6.49 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 411 | Uterine or vaginal bleeding | REPRO000044 | 6.47 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 412 | S100A12 levels | PROLV001767 | 6.44 | Protein levels | Lymphocyte | 6 | 3 | 14 | 39 | |
| 413 | PDP1 levels | PROLV001530 | 6.41 | Protein levels | Hepatocyte | 0 | 0 | 2 | 6 | |
| 414 | DLK1/RGMB ratio | PRORT000913 | 6.41 | Protein ratios | Hepatocyte | 11 | 4 | 9 | 23 | |
| 415 | CCDC80/CHRDL1 ratio | PRORT000333 | 6.40 | Protein ratios | Vascular | 10 | 1 | 5 | 15 | |
| 416 | ABL1/CC2D1A ratio | PRORT000008 | 6.36 | Protein ratios | Lymphocyte | 4 | 1 | 7 | 21 | |
| 417 | GBP2 levels | PROLV000861 | 6.34 | Protein levels | Myeloid | 0 | 2 | 11 | 16 | |
| 418 | GPHA2 levels | PROLV000922 | 6.30 | Protein levels | Stromal / connective | 9 | 0 | 2 | 3 | |
| 419 | IL17D levels | PROLV001052 | 6.29 | Protein levels | Hepatocyte | 18 | 4 | 8 | 25 | |
| 420 | Gut microbial abundance, CAG-177 | GASTR000020 | 6.28 | Gastrointestinal | Salivary epithelium | 0 | 0 | 7 | 5 | |
| 421 | TNC/VCAM1 ratio | PRORT001843 | 6.26 | Protein ratios | Adipose | 38 | 3 | 10 | 13 | |
| 422 | FSTL3/SPON2 ratio | PRORT001182 | 6.24 | Protein ratios | Hepatocyte | 3 | 2 | 9 | 23 | |
| 423 | Pregnancy complication, vomiting | REPRO000035 | 6.24 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 424 | CNTN4 levels | PROLV000478 | 6.23 | Protein levels | Myeloid | 28 | 0 | 1 | 5 | |
| 425 | PON1 levels | PROLV001600 | 6.20 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 426 | CD244/FCRL6 ratio | PRORT000408 | 6.20 | Protein ratios | Lymphocyte | 9 | 2 | 12 | 33 | |
| 427 | Tympanic membrane perforation | AUDIO000019 | 6.20 | Auditory | Stromal / connective | 5 | 3 | 6 | 8 | |
| 428 | Acute appendicitis | GASTR000009 | 6.20 | Gastrointestinal | Myeloid | 28 | 1 | 2 | 7 | |
| 429 | ICOSLG levels | PROLV001009 | 6.14 | Protein levels | Myeloid | 37 | 3 | 10 | 14 | |
| 430 | IL1R2 levels | PROLV001061 | 6.10 | Protein levels | Hepatocyte | 116 | 3 | 9 | 15 | |
| 431 | Biliary atresia | HPBIL000002 | 6.08 | Hepatopancreatobiliary | Stromal / connective | 0 | 2 | 8 | 6 | |
| 432 | Impacted cerumen | AUDIO000002 | 6.08 | Auditory | Salivary epithelium | 1 | 1 | 8 | 14 | |
| 433 | Optic cup area | OPHTH000028 | 6.07 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 434 | Family history, coronary artery disease | VASCU000021 | 6.07 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 435 | Short-chain fatty acids | METAB000053 | 6.06 | Metabolites | Granulosa cell | 20 | 5 | 12 | 17 | |
| 436 | Refractive errors | OPHTH000034 | 6.05 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 437 | BCAT1 levels | PROLV000183 | 6.04 | Protein levels | Stromal / connective | 43 | 3 | 9 | 26 | |
| 438 | RBP2 levels | PROLV001711 | 6.02 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 439 | OMD levels | PROLV001468 | 6.01 | Protein levels | Myeloid | 95 | 4 | 7 | 13 | |
| 440 | PI16 levels | PROLV001553 | 5.99 | Protein levels | Myeloid | 144 | 1 | 6 | 16 | |
| 441 | HNRNPUL1 levels | PROLV000983 | 5.99 | Protein levels | Lymphocyte | 15 | 4 | 11 | 41 | |
| 442 | DDHD2 levels | PROLV000609 | 5.98 | Protein levels | Vascular | 9 | 4 | 10 | 15 | |
| 443 | F9 levels | PROLV000750 | 5.95 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 444 | MOG/PTPRN2 ratio | PRORT001551 | 5.91 | Protein ratios | Neural / glial | 28 | 3 | 3 | 10 | |
| 445 | CFB levels | PROLV000410 | 5.90 | Protein levels | Hepatocyte | 101 | 4 | 14 | 24 | |
| 446 | ANKMY2 levels | PROLV000100 | 5.90 | Protein levels | Stromal / connective | 7 | 3 | 7 | 9 | |
| 447 | Family medical history, none | MISCL000010 | 5.90 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 448 | EGFR/MEGF9 ratio | PRORT001001 | 5.89 | Protein ratios | Hepatocyte | 28 | 1 | 5 | 9 | |
| 449 | MMP8/PGLYRP1 ratio | PRORT001544 | 5.88 | Protein ratios | Myeloid | 15 | 5 | 9 | 13 | |
| 450 | L1CAM levels | PROLV001171 | 5.84 | Protein levels | Vascular | 70 | 6 | 12 | 37 | |
| 451 | Precerebral arterial stenosis and occlusion | VASCU000016 | 5.84 | Vascular | Stromal / connective | 91 | 2 | 11 | 22 | |
| 452 | THBS4 levels | PROLV002027 | 5.83 | Protein levels | Hepatocyte | 69 | 2 | 8 | 18 | |
| 453 | BLVRB/CA2 ratio | PRORT000239 | 5.83 | Protein ratios | Vascular | 0 | 0 | 7 | 11 | |
| 454 | Chronic viral hepatitis | IMMUN000056 | 5.82 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 455 | RAD23B levels | PROLV001703 | 5.81 | Protein levels | Stromal / connective | 1 | 4 | 9 | 14 | |
| 456 | Endometriosis | REPRO000005 | 5.80 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 457 | CYTL1 levels | PROLV000589 | 5.80 | Protein levels | Stromal / connective | 2 | 2 | 4 | 6 | |
| 458 | NOTCH3/PTPRS ratio | PRORT001593 | 5.75 | Protein ratios | Vascular | 59 | 5 | 14 | 26 | |
| 459 | LTB4R levels | PROLV001241 | 5.73 | Protein levels | Myeloid | 8 | 3 | 12 | 18 | |
| 460 | ADAMTS8/FAP ratio | PRORT000026 | 5.69 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 461 | SLC39A5 levels | PROLV001881 | 5.68 | Protein levels | Hepatocyte | 133 | 4 | 11 | 29 | |
| 462 | Heart failure, with coronary heart disease | CARDI000005 | 5.68 | Cardiac | Stromal / connective | 54 | 3 | 9 | 17 | |
| 463 | Diffuse idiopathic skeletal hyperostosis | MSKEL000074 | 5.67 | Musculoskeletal | Hematopoietic progenitor | 1 | 2 | 6 | 16 | |
| 464 | SMPD1 levels | PROLV001901 | 5.67 | Protein levels | Hepatocyte | 179 | 1 | 7 | 16 | |
| 465 | AHNAK2 levels | PROLV000063 | 5.66 | Protein levels | Adipose | 19 | 0 | 2 | 13 | |
| 466 | ENO3 levels | PROLV000707 | 5.66 | Protein levels | Muscle / cardiac | 33 | 4 | 18 | 37 | |
| 467 | Macular puckering of retina | OPHTH000037 | 5.66 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 468 | AGT levels | PROLV000059 | 5.65 | Protein levels | Hepatocyte | 53 | 2 | 5 | 10 | |
| 469 | INHBB levels | PROLV001087 | 5.64 | Protein levels | Hepatocyte | 38 | 6 | 10 | 14 | |
| 470 | TPM2 levels | PROLV002095 | 5.64 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 471 | NCS1/NPY ratio | PRORT001576 | 5.63 | Protein ratios | Hepatocyte | 58 | 2 | 7 | 15 | |
| 472 | CCL8 levels | PROLV000300 | 5.60 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 473 | PDCD1LG2 levels | PROLV001516 | 5.59 | Protein levels | Hepatocyte | 48 | 1 | 7 | 10 | |
| 474 | Hearing loss, age-related | AUDIO000006 | 5.59 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 475 | CD40LG/TNFSF14 ratio | PRORT000454 | 5.58 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 476 | SNAP23/TBL1X ratio | PRORT001794 | 5.56 | Protein ratios | Myeloid | 9 | 3 | 13 | 22 | |
| 477 | MPHOSPH8/USP8 ratio | PRORT001555 | 5.56 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 478 | FN1 levels | PROLV000819 | 5.55 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 479 | FUT8/VEGFC ratio | PRORT001193 | 5.54 | Protein ratios | Vascular | 3 | 5 | 21 | 43 | |
| 480 | FOXJ3 levels | PROLV000825 | 5.53 | Protein levels | Stromal / connective | 0 | 5 | 9 | 28 | |
| 481 | Pneumonia | IMMUN000069 | 5.52 | Immunologic | Hepatocyte | 27 | 1 | 4 | 13 | |
| 482 | F7 levels | PROLV000748 | 5.51 | Protein levels | Hepatocyte | 89 | 1 | 8 | 15 | |
| 483 | Blood disorder | HEMAT000040 | 5.49 | Hematologic | Myeloid | 1 | 3 | 8 | 12 | |
| 484 | Isoleucine | METAB000024 | 5.48 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 485 | COL6A3 levels | PROLV000492 | 5.48 | Protein levels | Stromal / connective | 38 | 2 | 4 | 12 | |
| 486 | B4GALT1/SPON2 ratio | PRORT000190 | 5.48 | Protein ratios | Hepatocyte | 13 | 1 | 9 | 16 | |
| 487 | PON2/PON3 ratio | PRORT001698 | 5.47 | Protein ratios | Hepatocyte | 8 | 2 | 6 | 20 | |
| 488 | B4GAT1 levels | PROLV000172 | 5.47 | Protein levels | Myeloid | 147 | 2 | 8 | 9 | |
| 489 | CACNA2D3 levels | PROLV000250 | 5.46 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 490 | Coronary artery plaque burden | VASCU000056 | 5.43 | Vascular | Vascular | 37 | 3 | 5 | 9 | |
| 491 | Ocular motility and refraction disorder | OPHTH000024 | 5.41 | Ophthalmic | Adipose | 7 | 3 | 5 | 12 | |
| 492 | ITGAM levels | PROLV001109 | 5.41 | Protein levels | Myeloid | 94 | 2 | 11 | 15 | |
| 493 | SNX2 levels | PROLV001913 | 5.41 | Protein levels | B / plasma cell | 8 | 1 | 6 | 17 | |
| 494 | AHCY/FABP5 ratio | PRORT000054 | 5.40 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 14 | |
| 495 | EFEMP1/FSTL3 ratio | PRORT000986 | 5.40 | Protein ratios | Stromal / connective | 14 | 4 | 6 | 20 | |
| 496 | IL1B levels | PROLV001059 | 5.40 | Protein levels | Myeloid | 2 | 3 | 11 | 18 | |
| 497 | TSC22D1 levels | PROLV002113 | 5.38 | Protein levels | Stromal / connective | 4 | 2 | 9 | 10 | |
| 498 | Peripheral artery disease | VASCU000042 | 5.38 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 499 | NHLRC3 levels | PROLV001403 | 5.37 | Protein levels | Stromal / connective | 23 | 5 | 9 | 27 | |
| 500 | CDHR2 levels | PROLV000379 | 5.36 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 501 | ERBIN/TBC1D23 ratio | PRORT001052 | 5.36 | Protein ratios | Hepatocyte | 0 | 4 | 9 | 17 | |
| 502 | COMP/ITGAV ratio | PRORT000711 | 5.35 | Protein ratios | Myeloid | 58 | 3 | 11 | 18 | |
| 503 | BTD levels | PROLV000218 | 5.34 | Protein levels | Hepatocyte | 77 | 3 | 11 | 13 | |
| 504 | TGFBR3 levels | PROLV002023 | 5.33 | Protein levels | Adipose | 33 | 3 | 6 | 14 | |
| 505 | CC2D1A/TMSB10 ratio | PRORT000330 | 5.30 | Protein ratios | Myeloid | 4 | 3 | 11 | 27 | |
| 506 | DYNLL1 levels | PROLV000666 | 5.27 | Protein levels | B / plasma cell | 0 | 1 | 4 | 4 | |
| 507 | BCAN/MOG ratio | PRORT000217 | 5.26 | Protein ratios | Myeloid | 5 | 1 | 6 | 12 | |
| 508 | PTPRS levels | PROLV001681 | 5.22 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 509 | CRTAM/TNFRSF9 ratio | PRORT000774 | 5.21 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 510 | PTPRN2/RTBDN ratio | PRORT001724 | 5.21 | Protein ratios | Neural / glial | 7 | 2 | 6 | 18 | |
| 511 | Foot surgery | MSKEL000046 | 5.19 | Musculoskeletal | Hematopoietic progenitor | 2 | 2 | 6 | 12 | |
| 512 | PROC levels | PROLV001637 | 5.18 | Protein levels | Hepatocyte | 164 | 2 | 6 | 14 | |
| 513 | Fibromuscular dysplasia | VASCU000024 | 5.18 | Vascular | Stromal / connective | 1 | 3 | 6 | 11 | |
| 514 | ADGRE5/GAS6 ratio | PRORT000030 | 5.18 | Protein ratios | Myeloid | 116 | 4 | 10 | 23 | |
| 515 | IL3RA levels | PROLV001074 | 5.18 | Protein levels | Granulosa cell | 51 | 1 | 10 | 25 | |
| 516 | Cervical disorder | REPRO000001 | 5.17 | Reproductive | Stromal / connective | 8 | 2 | 9 | 19 | |
| 517 | ACVRL1/SCARB2 ratio | PRORT000015 | 5.15 | Protein ratios | Myeloid | 46 | 2 | 9 | 18 | |
| 518 | ANGPT2 levels | PROLV000094 | 5.15 | Protein levels | Hepatocyte | 72 | 3 | 10 | 21 | |
| 519 | PLG levels | PROLV001577 | 5.14 | Protein levels | Granulosa cell | 46 | 5 | 14 | 28 | |
| 520 | CDHR5 levels | PROLV000380 | 5.14 | Protein levels | Hepatocyte | 114 | 1 | 5 | 9 | |
| 521 | PTPRF/PTPRS ratio | PRORT001721 | 5.12 | Protein ratios | Hepatocyte | 76 | 4 | 11 | 24 | |
| 522 | AXL/MSR1 ratio | PRORT000182 | 5.12 | Protein ratios | Myeloid | 28 | 4 | 16 | 18 | |
| 523 | Organic acids | METAB000068 | 5.12 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 524 | ERBB2/FURIN ratio | PRORT001042 | 5.07 | Protein ratios | Hepatocyte | 39 | 2 | 7 | 17 | |
| 525 | ITGB1 levels | PROLV001111 | 5.05 | Protein levels | Myeloid | 78 | 4 | 10 | 28 | |
| 526 | Eye disorder, none | OPHTH000007 | 5.05 | Ophthalmic | Neural / glial | — | 4 | 14 | 11 | |
| 527 | NAAA levels | PROLV001369 | 5.03 | Protein levels | Hepatocyte | 124 | 1 | 5 | 11 | |
| 528 | Body fat percentage, hormone-adjusted | BCOMP000001 | 4.99 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 529 | NCR1 levels | PROLV001382 | 4.98 | Protein levels | Lymphocyte | 117 | 2 | 14 | 32 | |
| 530 | FURIN levels | PROLV000835 | 4.98 | Protein levels | Myeloid | 29 | 3 | 8 | 13 | |
| 531 | APOA4 levels | PROLV000119 | 4.97 | Protein levels | Granulosa cell | 12 | 0 | 5 | 7 | |
| 532 | Alpha-1-antitrypsin deficiency | RESPI000005 | 4.86 | Respiratory | Granulosa cell | 4 | 3 | 10 | 14 | |
| 533 | AOC3/ITGB1 ratio | PRORT000113 | 4.85 | Protein ratios | Stromal / connective | 16 | 3 | 14 | 10 | |
| 534 | COLEC12/TGFBR2 ratio | PRORT000707 | 4.84 | Protein ratios | Hepatocyte | 75 | 3 | 8 | 18 | |
| 535 | EPCAM levels | PROLV000715 | 4.83 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 536 | CCL2 levels | PROLV000286 | 4.83 | Protein levels | Myeloid | 106 | 3 | 6 | 7 | |
| 537 | HLA-DQA2 levels | PROLV000974 | 4.82 | Protein levels | Neural / glial | 5 | 4 | 7 | 9 | |
| 538 | Angina pectoris | CARDI000039 | 4.82 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 539 | Infertility | REPRO000010 | 4.81 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 540 | SKAP2/VSIR ratio | PRORT001788 | 4.81 | Protein ratios | Myeloid | 7 | 4 | 17 | 18 | |
| 541 | ACVRL1/TNFRSF19 ratio | PRORT000017 | 4.76 | Protein ratios | Vascular | 20 | 2 | 7 | 15 | |
| 542 | CTSL levels | PROLV000566 | 4.76 | Protein levels | Myeloid | 163 | 2 | 9 | 15 | |
| 543 | Intracerebral haemorrhage | VASCU000014 | 4.76 | Vascular | Stromal / connective | 0 | 6 | 14 | 20 | |
| 544 | Enamel hypoplasia | DENTA000002 | 4.76 | Dental | Vascular | 0 | 0 | 13 | 48 | |
| 545 | FUCA1 levels | PROLV000833 | 4.76 | Protein levels | Hepatocyte | 40 | 2 | 10 | 18 | |
| 546 | TP53I3 levels | PROLV002091 | 4.75 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 547 | CLU levels | PROLV000467 | 4.75 | Protein levels | Granulosa cell | 75 | 5 | 15 | 24 | |
| 548 | F9/PROC ratio | PRORT001092 | 4.73 | Protein ratios | Myeloid | 14 | 2 | 10 | 11 | |
| 549 | CDH2/CDHR2 ratio | PRORT000552 | 4.73 | Protein ratios | Hepatocyte | 39 | 1 | 6 | 11 | |
| 550 | GPD1 levels | PROLV000921 | 4.70 | Protein levels | Neural / glial | 0 | 3 | 7 | 11 | |
| 551 | ASGR1/DCBLD2 ratio | PRORT000147 | 4.70 | Protein ratios | Hepatocyte | 92 | 3 | 9 | 19 | |
| 552 | HYOU1/THBD ratio | PRORT001318 | 4.69 | Protein ratios | Hepatocyte | 54 | 2 | 7 | 23 | |
| 553 | GZMA/TNFRSF8 ratio | PRORT001262 | 4.69 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 554 | FABP2 levels | PROLV000752 | 4.69 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 555 | GPA33 levels | PROLV000918 | 4.68 | Protein levels | Vascular | 66 | 2 | 10 | 11 | |
| 556 | Liver enzyme elevation | HPBIL000019 | 4.67 | Hepatopancreatobiliary | Myeloid | 3 | 2 | 6 | 24 | |
| 557 | Cardiac pacemaker | CARDI000049 | 4.67 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 558 | FOLH1 levels | PROLV000821 | 4.67 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 559 | SCARA5/TNC ratio | PRORT001760 | 4.66 | Protein ratios | Granulosa cell | 39 | 2 | 9 | 13 | |
| 560 | CILP levels | PROLV000436 | 4.65 | Protein levels | Myeloid | 47 | 5 | 12 | 21 | |
| 561 | Fall risk | MSKEL000043 | 4.63 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 562 | Tonsillar and adenoidal disorders | RESPI000040 | 4.63 | Respiratory | Myeloid | 125 | 2 | 10 | 27 | |
| 563 | CD27/TNFRSF9 ratio | PRORT000419 | 4.63 | Protein ratios | B / plasma cell | 20 | 5 | 15 | 40 | |
| 564 | Fatty liver disease, nonalcoholic | HPBIL000031 | 4.62 | Hepatopancreatobiliary | Vascular | 19 | 1 | 7 | 16 | |
| 565 | Cardiac procedure, angioplasty | VASCU000057 | 4.61 | Vascular | Vascular | 102 | 4 | 10 | 20 | |
| 566 | LAT2/SERPINB1 ratio | PRORT001431 | 4.59 | Protein ratios | Hepatocyte | 1 | 4 | 13 | 30 | |
| 567 | XRCC4 levels | PROLV002200 | 4.57 | Protein levels | Myeloid | 0 | 4 | 9 | 17 | |
| 568 | Hip joint morphology | MSKEL000023 | 4.56 | Musculoskeletal | Stromal / connective | 56 | 2 | 4 | 7 | |
| 569 | PDGFB/SPARC ratio | PRORT001645 | 4.56 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 570 | DCTN6 levels | PROLV000604 | 4.55 | Protein levels | Vascular | 0 | 4 | 13 | 31 | |
| 571 | PATE4 levels | PROLV001498 | 4.55 | Protein levels | Muscle / cardiac | 0 | 2 | 9 | 19 | |
| 572 | EIF4G1/MAVS ratio | PRORT001011 | 4.55 | Protein ratios | Myeloid | 22 | 3 | 9 | 16 | |
| 573 | EFNA1 levels | PROLV000681 | 4.55 | Protein levels | Vascular | 45 | 2 | 11 | 22 | |
| 574 | LTBP2/MYOC ratio | PRORT001464 | 4.53 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 575 | Gut microbial abundance, Alistipes | GASTR000018 | 4.52 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 576 | Pain, back | MSKEL000033 | 4.51 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 577 | Operation, gastrointestinal | GASTR000039 | 4.50 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 578 | CHI3L1/HSPG2 ratio | PRORT000610 | 4.49 | Protein ratios | Hepatocyte | 10 | 2 | 9 | 26 | |
| 579 | CCDC80/CCL27 ratio | PRORT000332 | 4.48 | Protein ratios | Myeloid | 40 | 3 | 6 | 28 | |
| 580 | SNX15 levels | PROLV001911 | 4.48 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 581 | LGALS8/VWF ratio | PRORT001455 | 4.47 | Protein ratios | Granulosa cell | 1 | 4 | 10 | 24 | |
| 582 | Arthropathy | MSKEL000013 | 4.44 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 583 | MIF/SUSD2 ratio | PRORT001535 | 4.44 | Protein ratios | Vascular | 33 | 1 | 7 | 22 | |
| 584 | ADGRE5/NOTCH1 ratio | PRORT000032 | 4.44 | Protein ratios | Myeloid | 54 | 3 | 13 | 15 | |
| 585 | FCGR3B levels | PROLV000780 | 4.43 | Protein levels | Myeloid | 115 | 2 | 9 | 12 | |
| 586 | GABARAPL1 levels | PROLV000844 | 4.41 | Protein levels | Hepatocyte | — | 2 | 8 | 14 | |
| 587 | ACYP1 levels | PROLV000021 | 4.41 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 588 | Cortical volume | NIMAG000022 | 4.39 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 589 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 4.39 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 590 | Upper respiratory inflammation | RESPI000041 | 4.37 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 591 | CA2/UBAC1 ratio | PRORT000279 | 4.37 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 592 | MAN1A2 levels | PROLV001260 | 4.36 | Protein levels | Myeloid | 160 | 3 | 12 | 14 | |
| 593 | Biventricular shape | CARDI000010 | 4.34 | Cardiac | Muscle / cardiac | 44 | 2 | 4 | 12 | |
| 594 | Acquired absence of organs | MISCL000027 | 4.34 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 595 | Atherosclerosis | VASCU000006 | 4.33 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 596 | CD48 levels | PROLV000343 | 4.31 | Protein levels | B / plasma cell | 92 | 2 | 8 | 19 | |
| 597 | Aortic elasticity | VASCU000049 | 4.31 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 598 | IL6ST levels | PROLV001079 | 4.30 | Protein levels | Hepatocyte | 62 | 2 | 7 | 15 | |
| 599 | FCRL6/GZMA ratio | PRORT001137 | 4.30 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 600 | Cardiac implants and grafts | CARDI000048 | 4.30 | Cardiac | Vascular | 36 | 4 | 9 | 23 | |
| 601 | Corrective lens use | OPHTH000032 | 4.28 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 602 | PRR15 levels | PROLV001641 | 4.28 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 603 | HYOU1/TGFBR3 ratio | PRORT001317 | 4.28 | Protein ratios | Hepatocyte | 27 | 2 | 8 | 23 | |
| 604 | MEGF9/MET ratio | PRORT001513 | 4.25 | Protein ratios | Hepatocyte | 46 | 1 | 5 | 7 | |
| 605 | Stimulant use disorder | PSYCH000048 | 4.24 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 606 | Arterial stiffness | VASCU000050 | 4.23 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 607 | Emphysema | RESPI000011 | 4.22 | Respiratory | Hepatocyte | 1 | 1 | 7 | 16 | |
| 608 | SCARA5/SCARF2 ratio | PRORT001758 | 4.22 | Protein ratios | Vascular | 4 | 1 | 3 | 18 | |
| 609 | ITPA levels | PROLV001121 | 4.21 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 21 | |
| 610 | CFHR5 levels | PROLV000417 | 4.21 | Protein levels | Hepatocyte | 18 | 3 | 9 | 16 | |
| 611 | PLAT levels | PROLV001571 | 4.20 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 612 | APP/CD40LG ratio | PRORT000122 | 4.20 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 13 | 32 | |
| 613 | CLEC1B/VSIR ratio | PRORT000652 | 4.18 | Protein ratios | Myeloid | 26 | 6 | 14 | 19 | |
| 614 | Adhesive capsulitis | MSKEL000058 | 4.18 | Musculoskeletal | Stromal / connective | 26 | 1 | 5 | 13 | |
| 615 | ESAM/TGFB1 ratio | PRORT001067 | 4.17 | Protein ratios | Muscle / cardiac | 20 | 4 | 11 | 17 | |
| 616 | Coronary revascularization | VASCU000059 | 4.16 | Vascular | Vascular | 384 | 4 | 9 | 25 | |
| 617 | Male genital disorder | REPRO000013 | 4.16 | Reproductive | Granulosa cell | 7 | 0 | 7 | 9 | |
| 618 | JAM2/TGFBR2 ratio | PRORT001397 | 4.16 | Protein ratios | Adipose | 13 | 0 | 4 | 8 | |
| 619 | FSHB levels | PROLV000828 | 4.14 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 620 | CHL1 levels | PROLV000430 | 4.13 | Protein levels | Hepatocyte | 10 | 3 | 6 | 15 | |
| 621 | CPXM2 levels | PROLV000512 | 4.11 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 14 | |
| 622 | Liver iron content | HPBIL000024 | 4.10 | Hepatopancreatobiliary | Hematopoietic progenitor | 23 | 1 | 9 | 14 | |
| 623 | HRC levels | PROLV000987 | 4.10 | Protein levels | Stromal / connective | 43 | 5 | 12 | 32 | |
| 624 | IFNGR1/THBD ratio | PRORT001332 | 4.08 | Protein ratios | Vascular | 22 | 3 | 9 | 14 | |
| 625 | CXCL5 levels | PROLV000584 | 4.08 | Protein levels | Platelet | 0 | 1 | 4 | 10 | |
| 626 | SLC27A4/TDRKH ratio | PRORT001790 | 4.08 | Protein ratios | Stromal / connective | 0 | 1 | 4 | 11 | |
| 627 | FGF5 levels | PROLV000797 | 4.06 | Protein levels | Hepatocyte | 31 | 3 | 5 | 10 | |
| 628 | FLT3 levels | PROLV000816 | 4.06 | Protein levels | Myeloid | 50 | 4 | 11 | 22 | |
| 629 | Membranous nephropathy | NEPHR000008 | 4.05 | Nephrourologic | Myeloid | 15 | 7 | 16 | 25 | |
| 630 | SRP14 levels | PROLV001943 | 4.04 | Protein levels | Lymphocyte | 4 | 2 | 14 | 26 | |
| 631 | CREG1/SMPDL3A ratio | PRORT000753 | 4.03 | Protein ratios | Hepatocyte | 10 | 2 | 10 | 28 | |
| 632 | Acylcarnitines | METAB000038 | 4.02 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 633 | AGRP/NPY ratio | PRORT000050 | 4.02 | Protein ratios | Hepatocyte | 28 | 1 | 9 | 10 | |
| 634 | Cutaneous haemangioma | DERMA000003 | 4.02 | Dermatologic | Myeloid | 1 | 1 | 7 | 12 | |
| 635 | Retinal disorder | OPHTH000040 | 4.00 | Ophthalmic | Hepatocyte | 88 | 0 | 2 | 3 | |
| 636 | Liver fat | HPBIL000023 | 3.99 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 637 | ECG-predicted BMI discrepancy | BMORP000008 | 3.99 | Body morphology | Muscle / cardiac | 0 | 2 | 5 | 20 | |
| 638 | TINAGL1 levels | PROLV002041 | 3.99 | Protein levels | Vascular | 55 | 4 | 8 | 15 | |
| 639 | IGDCC4 levels | PROLV001024 | 3.99 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 640 | PDLIM7/SRC ratio | PRORT001655 | 3.98 | Protein ratios | Myeloid | 12 | 3 | 7 | 20 | |
| 641 | ERBB2 levels | PROLV000724 | 3.98 | Protein levels | Hepatocyte | 97 | 1 | 8 | 17 | |
| 642 | GHR levels | PROLV000885 | 3.94 | Protein levels | Hepatocyte | 17 | 2 | 7 | 23 | |
| 643 | LTBR levels | PROLV001244 | 3.94 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 644 | HEG1 levels | PROLV000961 | 3.93 | Protein levels | Vascular | 51 | 3 | 7 | 16 | |
| 645 | CD163/MSR1 ratio | PRORT000384 | 3.92 | Protein ratios | Myeloid | 62 | 3 | 10 | 14 | |
| 646 | COL6A3/TAFA5 ratio | PRORT000702 | 3.91 | Protein ratios | Hepatocyte | 31 | 5 | 7 | 24 | |
| 647 | HGF/MMP8 ratio | PRORT001282 | 3.91 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 19 | |
| 648 | SCARA3 levels | PROLV001779 | 3.91 | Protein levels | Epithelial | 0 | 1 | 16 | 30 | |
| 649 | Facial ageing | DERMA000039 | 3.91 | Dermatologic | Melanocyte | 22 | 0 | 0 | 0 | |
| 650 | ALB levels | PROLV000077 | 3.89 | Protein levels | Myeloid | 1,602 | 3 | 15 | 21 | |
| 651 | MITD1/SNX9 ratio | PRORT001537 | 3.88 | Protein ratios | Hepatocyte | 2 | 5 | 13 | 26 | |
| 652 | CA2/TGM2 ratio | PRORT000278 | 3.88 | Protein ratios | Epithelial | 17 | 3 | 7 | 15 | |
| 653 | ENPP5 levels | PROLV000709 | 3.87 | Protein levels | Myeloid | 71 | 4 | 11 | 13 | |
| 654 | CNTN5/ROBO2 ratio | PRORT000688 | 3.87 | Protein ratios | Myeloid | 1 | 4 | 12 | 19 | |
| 655 | VEGFD levels | PROLV002160 | 3.87 | Protein levels | Hepatocyte | 25 | 2 | 9 | 23 | |
| 656 | SCLY/SORD ratio | PRORT001764 | 3.86 | Protein ratios | Myeloid | 1 | 3 | 10 | 16 | |
| 657 | SERPINE1/USP8 ratio | PRORT001779 | 3.86 | Protein ratios | Lymphocyte | 0 | 4 | 16 | 40 | |
| 658 | CD99L2/CPM ratio | PRORT000538 | 3.85 | Protein ratios | Hepatocyte | 28 | 2 | 10 | 16 | |
| 659 | ATXN10 levels | PROLV000164 | 3.84 | Protein levels | Vascular | 7 | 3 | 9 | 20 | |
| 660 | ELAC1 levels | PROLV000699 | 3.79 | Protein levels | Lymphocyte | 2 | 3 | 8 | 33 | |
| 661 | Family history, chronic lung disease | RESPI000002 | 3.78 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 662 | ROBO1 levels | PROLV001749 | 3.78 | Protein levels | Myeloid | 129 | 2 | 7 | 15 | |
| 663 | TARBP2/TDRKH ratio | PRORT001826 | 3.78 | Protein ratios | Granulosa cell | 0 | 3 | 8 | 16 | |
| 664 | KIAA2013 levels | PROLV001138 | 3.77 | Protein levels | Myeloid | — | 3 | 14 | 23 | |
| 665 | ANPEP levels | PROLV000103 | 3.77 | Protein levels | Hepatocyte | 62 | 1 | 8 | 18 | |
| 666 | GFRA3/LAYN ratio | PRORT001211 | 3.77 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 667 | TNFRSF8/TNFRSF9 ratio | PRORT001855 | 3.77 | Protein ratios | Myeloid | 3 | 4 | 12 | 23 | |
| 668 | MANSC1/PODXL ratio | PRORT001483 | 3.76 | Protein ratios | Hepatocyte | 5 | 1 | 8 | 13 | |
| 669 | LCN2/S100A12 ratio | PRORT001444 | 3.76 | Protein ratios | Myeloid | 28 | 4 | 18 | 35 | |
| 670 | Chondrocalcinosis | MSKEL000014 | 3.74 | Musculoskeletal | Vascular | 0 | 1 | 6 | 12 | |
| 671 | LIFR levels | PROLV001210 | 3.72 | Protein levels | Vascular | 75 | 4 | 12 | 46 | |
| 672 | NEO1 levels | PROLV001392 | 3.72 | Protein levels | Muscle / cardiac | 0 | 3 | 11 | 19 | |
| 673 | LAG3/VCAM1 ratio | PRORT001418 | 3.71 | Protein ratios | Hepatocyte | 24 | 4 | 13 | 36 | |
| 674 | AXIN1/MAVS ratio | PRORT000175 | 3.71 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 675 | Trigger finger | MSKEL000072 | 3.71 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 676 | PDAP1 levels | PROLV001514 | 3.69 | Protein levels | Stromal / connective | 4 | 3 | 6 | 16 | |
| 677 | ALCAM levels | PROLV000078 | 3.69 | Protein levels | Hepatocyte | 193 | 3 | 13 | 31 | |
| 678 | MYOC/NOTCH3 ratio | PRORT001566 | 3.67 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 679 | Depression or anxiety | PSYCH000025 | 3.66 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 680 | APOE levels | PROLV000124 | 3.65 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 681 | Pregnancy complication, obstructed labour | REPRO000031 | 3.65 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 682 | SEZ6L2 levels | PROLV001842 | 3.64 | Protein levels | Myeloid | 148 | 2 | 6 | 12 | |
| 683 | IGFBP4/OGN ratio | PRORT001335 | 3.63 | Protein ratios | Stromal / connective | 0 | 2 | 11 | 29 | |
| 684 | Valvular heart disease | CARDI000054 | 3.63 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 685 | EGF/TNFSF14 ratio | PRORT000999 | 3.63 | Protein ratios | Hepatocyte | 12 | 4 | 17 | 36 | |
| 686 | MPIG6B/PDGFB ratio | PRORT001557 | 3.62 | Protein ratios | Myeloid | 3 | 4 | 11 | 21 | |
| 687 | MSR1 levels | PROLV001342 | 3.62 | Protein levels | Myeloid | 116 | 3 | 10 | 13 | |
| 688 | Ocular alignment disorder | OPHTH000023 | 3.61 | Ophthalmic | Myeloid | 9 | 4 | 9 | 17 | |
| 689 | FHIT/PMVK ratio | PRORT001147 | 3.61 | Protein ratios | Myeloid | 0 | 2 | 8 | 24 | |
| 690 | STIP1/TMSB10 ratio | PRORT001818 | 3.61 | Protein ratios | Muscle / cardiac | 13 | 3 | 8 | 22 | |
| 691 | CRIM1 levels | PROLV000522 | 3.59 | Protein levels | Vascular | 58 | 2 | 9 | 16 | |
| 692 | KIFBP/TBC1D23 ratio | PRORT001405 | 3.59 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 24 | |
| 693 | ADAMTSL4 levels | PROLV000037 | 3.58 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 694 | FKBP5/TBCC ratio | PRORT001159 | 3.58 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 14 | |
| 695 | SERPINB8 levels | PROLV001826 | 3.56 | Protein levels | Myeloid | 18 | 5 | 6 | 17 | |
| 696 | CCL17/F2R ratio | PRORT000344 | 3.55 | Protein ratios | Myeloid | 16 | 4 | 12 | 35 | |
| 697 | CSF volume | NIMAG000018 | 3.55 | Neuroimaging | Stromal / connective | 16 | 2 | 2 | 6 | |
| 698 | LEPR/NTRK2 ratio | PRORT001448 | 3.55 | Protein ratios | Neural / glial | 24 | 4 | 10 | 21 | |
| 699 | SCARF2/TNFRSF21 ratio | PRORT001763 | 3.54 | Protein ratios | Myeloid | 9 | 5 | 8 | 25 | |
| 700 | AAMDC levels | PROLV000004 | 3.53 | Protein levels | Myeloid | 19 | 1 | 5 | 7 | |
| 701 | CIAPIN1/SPARC ratio | PRORT000618 | 3.53 | Protein ratios | Myeloid | 9 | 1 | 8 | 13 | |
| 702 | Valine | METAB000032 | 3.52 | Metabolites | Hepatocyte | 209 | 2 | 6 | 18 | |
| 703 | PON3 levels | PROLV001602 | 3.51 | Protein levels | Hepatocyte | 81 | 4 | 9 | 26 | |
| 704 | RNASEH2A levels | PROLV001741 | 3.51 | Protein levels | Neural / glial | 5 | 3 | 11 | 24 | |
| 705 | NRGN levels | PROLV001433 | 3.50 | Protein levels | Stromal / connective | 2 | 4 | 10 | 27 | |
| 706 | MIA/NBL1 ratio | PRORT001532 | 3.49 | Protein ratios | Stromal / connective | 22 | 3 | 7 | 17 | |
| 707 | Smoking dependency | PSYCH000047 | 3.49 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 708 | FHIT/PARK7 ratio | PRORT001146 | 3.49 | Protein ratios | Myeloid | 3 | 4 | 12 | 20 | |
| 709 | AKT2 levels | PROLV000075 | 3.49 | Protein levels | Stromal / connective | 6 | 3 | 10 | 21 | |
| 710 | AXL/GAS6 ratio | PRORT000179 | 3.48 | Protein ratios | Myeloid | 29 | 3 | 9 | 19 | |
| 711 | ALCAM/MSR1 ratio | PRORT000074 | 3.47 | Protein ratios | Myeloid | 30 | 2 | 10 | 13 | |
| 712 | CKAP2 levels | PROLV000438 | 3.46 | Protein levels | Neural / glial | 1 | 4 | 7 | 19 | |
| 713 | MPI levels | PROLV001334 | 3.44 | Protein levels | Stromal / connective | 10 | 5 | 10 | 15 | |
| 714 | Brain MRI signal intensity | NIMAG000003 | 3.43 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 715 | AHSA1 levels | PROLV000064 | 3.43 | Protein levels | Vascular | 1 | 0 | 2 | 16 | |
| 716 | CRTAC1 levels | PROLV000529 | 3.43 | Protein levels | Myeloid | 136 | 2 | 12 | 16 | |
| 717 | Malocclusion | DENTA000008 | 3.42 | Dental | Stromal / connective | 0 | 0 | 1 | 2 | |
| 718 | Cortical surface area | NIMAG000009 | 3.41 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 719 | Corneal disorder | OPHTH000003 | 3.41 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 720 | FGFR2 levels | PROLV000801 | 3.40 | Protein levels | Adipose | 45 | 0 | 5 | 11 | |
| 721 | CASP10/ING1 ratio | PRORT000311 | 3.39 | Protein ratios | Lymphocyte | 4 | 3 | 11 | 36 | |
| 722 | Amygdala volume | NIMAG000014 | 3.38 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 723 | APP/NID2 ratio | PRORT000129 | 3.37 | Protein ratios | Stromal / connective | 0 | 2 | 6 | 11 | |
| 724 | White matter microstructure | NIMAG000013 | 3.37 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 725 | MEGF9/OXT ratio | PRORT001514 | 3.36 | Protein ratios | Hepatocyte | 34 | 1 | 4 | 15 | |
| 726 | Body water mass | BCOMP000006 | 3.35 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 727 | ADAMTS16 levels | PROLV000033 | 3.34 | Protein levels | Myeloid | 3 | 1 | 2 | 10 | |
| 728 | CDH3/NECTIN4 ratio | PRORT000554 | 3.32 | Protein ratios | Respiratory epithelium | 19 | 0 | 10 | 9 | |
| 729 | ROBO1/SPON1 ratio | PRORT001744 | 3.32 | Protein ratios | Vascular | 3 | 3 | 7 | 12 | |
| 730 | Ventricular wall thickness | CARDI000016 | 3.32 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 731 | LY75 levels | PROLV001248 | 3.31 | Protein levels | Myeloid | 56 | 2 | 6 | 16 | |
| 732 | PMVK levels | PROLV001590 | 3.31 | Protein levels | Myeloid | 34 | 3 | 8 | 12 | |
| 733 | AMBP/EFEMP1 ratio | PRORT000085 | 3.31 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 11 | |
| 734 | BAX levels | PROLV000180 | 3.30 | Protein levels | Vascular | 2 | 5 | 7 | 20 | |
| 735 | Labour complication | REPRO000037 | 3.30 | Reproductive | Stromal / connective | 0 | 1 | 4 | 7 | |
| 736 | APEX1/LSP1 ratio | PRORT000116 | 3.29 | Protein ratios | Myeloid | 14 | 4 | 9 | 14 | |
| 737 | CLEC5A levels | PROLV000455 | 3.28 | Protein levels | Myeloid | 94 | 2 | 9 | 10 | |
| 738 | CFHR4 levels | PROLV000416 | 3.28 | Protein levels | Hepatocyte | 61 | 2 | 9 | 16 | |
| 739 | C5 levels | PROLV000235 | 3.27 | Protein levels | Hepatocyte | 10 | 4 | 15 | 40 | |
| 740 | Sexually transmitted infection | IMMUN000072 | 3.27 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 741 | CD93 levels | PROLV000362 | 3.27 | Protein levels | Granulosa cell | 47 | 1 | 5 | 10 | |
| 742 | NOTCH3 levels | PROLV001418 | 3.26 | Protein levels | Hepatocyte | 166 | 2 | 12 | 29 | |
| 743 | PNLIPRP2 levels | PROLV001593 | 3.25 | Protein levels | Granulosa cell | 13 | 1 | 5 | 13 | |
| 744 | CST6 levels | PROLV000551 | 3.25 | Protein levels | Cutaneous epithelium | 33 | 1 | 10 | 10 | |
| 745 | AIDA levels | PROLV000067 | 3.24 | Protein levels | B / plasma cell | — | 2 | 5 | 25 | |
| 746 | FURIN/INHBC ratio | PRORT001184 | 3.24 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 23 | |
| 747 | Hearing aid use | AUDIO000011 | 3.24 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 748 | Keloid and scarring | DERMA000041 | 3.22 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 749 | CASP8/DDX58 ratio | PRORT000321 | 3.20 | Protein ratios | Myeloid | 2 | 2 | 8 | 11 | |
| 750 | Cataract | OPHTH000012 | 3.20 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 751 | C-reactive protein | HPBIL000026 | 3.20 | Hepatopancreatobiliary | Hepatocyte | 1,267 | 3 | 10 | 20 | |
| 752 | BST1 levels | PROLV000215 | 3.19 | Protein levels | Myeloid | 31 | 1 | 5 | 7 | |
| 753 | CA5A/GRPEL1 ratio | PRORT000286 | 3.18 | Protein ratios | Hepatocyte | 44 | 3 | 12 | 25 | |
| 754 | Dysmenorrhea | REPRO000019 | 3.17 | Reproductive | Myeloid | 1 | 2 | 6 | 12 | |
| 755 | PCDHB15 levels | PROLV001509 | 3.17 | Protein levels | Vascular | 46 | 2 | 6 | 9 | |
| 756 | FLRT2 levels | PROLV000814 | 3.17 | Protein levels | Hepatocyte | 50 | 1 | 6 | 14 | |
| 757 | PTPRH levels | PROLV001676 | 3.16 | Protein levels | Vascular | 69 | 3 | 7 | 15 | |
| 758 | JAM2/TNFRSF21 ratio | PRORT001401 | 3.15 | Protein ratios | Vascular | 4 | 1 | 6 | 7 | |
| 759 | APOA2 levels | PROLV000118 | 3.15 | Protein levels | Hepatocyte | 134 | 3 | 9 | 20 | |
| 760 | SSC5D levels | PROLV001948 | 3.13 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 761 | Liver enzyme levels, ALP | HPBIL000012 | 3.12 | Hepatopancreatobiliary | Hepatocyte | 1,521 | 1 | 5 | 16 | |
| 762 | Hydrocephalus | NEURO000002 | 3.12 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 763 | CAMK1D levels | PROLV000259 | 3.11 | Protein levels | Hepatocyte | 9 | 2 | 8 | 12 | |
| 764 | ITGA5/LILRA2 ratio | PRORT001371 | 3.10 | Protein ratios | Hepatocyte | 38 | 3 | 12 | 20 | |
| 765 | IGF1 levels | PROLV001025 | 3.10 | Protein levels | Hepatocyte | 1,341 | 1 | 7 | 13 | |
| 766 | CXCL17/SFTPA2 ratio | PRORT000824 | 3.10 | Protein ratios | Myeloid | 3 | 2 | 8 | 18 | |
| 767 | Grey matter volume | NIMAG000023 | 3.09 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 768 | ALPI levels | PROLV000082 | 3.09 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 769 | GRN levels | PROLV000933 | 3.08 | Protein levels | Myeloid | 36 | 1 | 4 | 9 | |
| 770 | NTN1 levels | PROLV001444 | 3.07 | Protein levels | B / plasma cell | 0 | 1 | 3 | 14 | |
| 771 | Sugar alcohols | METAB000037 | 3.07 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 772 | CD69/CDKN2D ratio | PRORT000487 | 3.07 | Protein ratios | Vascular | 6 | 3 | 8 | 16 | |
| 773 | UBXN1 levels | PROLV002134 | 3.06 | Protein levels | Lymphocyte | 5 | 4 | 15 | 38 | |
| 774 | CD59/CST6 ratio | PRORT000481 | 3.04 | Protein ratios | Respiratory epithelium | 3 | 0 | 12 | 7 | |
| 775 | Medication, antipyretic | MISCL000035 | 3.04 | Miscellaneous | Lymphocyte | 0 | 3 | 10 | 20 | |
| 776 | Spondylosis | MSKEL000081 | 3.03 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 777 | Medication, post-myocardial infarction | CARDI000045 | 3.03 | Cardiac | Vascular | 76 | 4 | 9 | 11 | |
| 778 | CNTN1/EGFR ratio | PRORT000685 | 3.02 | Protein ratios | Hepatocyte | 69 | 2 | 10 | 12 | |
| 779 | SGSH levels | PROLV001850 | 3.02 | Protein levels | Myeloid | 70 | 3 | 11 | 22 | |
| 780 | LTBR/TNFRSF14 ratio | PRORT001467 | 3.02 | Protein ratios | Stromal / connective | 0 | 4 | 11 | 23 | |
| 781 | CD38/RELT ratio | PRORT000440 | 3.02 | Protein ratios | Muscle / cardiac | 2 | 2 | 9 | 17 | |
| 782 | Coronary artery disease, CAD | VASCU000020 | 3.02 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 783 | ACVRL1/TNFRSF9 ratio | PRORT000018 | 3.01 | Protein ratios | Myeloid | 12 | 2 | 11 | 19 | |
| 784 | CASP10 levels | PROLV000266 | 3.01 | Protein levels | Lymphocyte | 3 | 4 | 11 | 33 | |
| 785 | Total protein levels | PROLV002131 | 2.99 | Protein levels | Myeloid | 897 | 4 | 12 | 26 | |
| 786 | C3 levels | PROLV000232 | 2.98 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 787 | TNFSF14 levels | PROLV002080 | 2.98 | Protein levels | Myeloid | 15 | 2 | 6 | 24 | |
| 788 | Leg mass | BCOMP000017 | 2.98 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 789 | CELA3A/CTRB1 ratio | PRORT000595 | 2.98 | Protein ratios | Vascular | 12 | 2 | 6 | 9 | |
| 790 | Tryptophan metabolites | METAB000015 | 2.98 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 791 | MSRA/P4HB ratio | PRORT001561 | 2.98 | Protein ratios | Neural / glial | 24 | 6 | 15 | 25 | |
| 792 | AXIN1/IKBKG ratio | PRORT000171 | 2.96 | Protein ratios | Muscle / cardiac | 10 | 5 | 13 | 29 | |
| 793 | Osteochondrodysplasia | MSKEL000054 | 2.96 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 794 | DBNL/PDGFB ratio | PRORT000868 | 2.96 | Protein ratios | Myeloid | 35 | 4 | 13 | 18 | |
| 795 | Cardiovascular age gap | CARDI000001 | 2.95 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 796 | SRC/TBL1X ratio | PRORT001814 | 2.95 | Protein ratios | Platelet | 1 | 4 | 11 | 15 | |
| 797 | Phosphate | METAB000048 | 2.94 | Metabolites | Hepatocyte | 604 | 1 | 7 | 10 | |
| 798 | CD302 levels | PROLV000334 | 2.93 | Protein levels | Myeloid | 157 | 1 | 13 | 19 | |
| 799 | SLC27A4 levels | PROLV001878 | 2.93 | Protein levels | Muscle / cardiac | 1 | 3 | 9 | 20 | |
| 800 | ICAM2 levels | PROLV001005 | 2.92 | Protein levels | Vascular | 38 | 4 | 7 | 20 | |
| 801 | Retinal vascular morphology | OPHTH000045 | 2.92 | Ophthalmic | Vascular | 253 | 2 | 5 | 7 | |
| 802 | Abnormal heart sounds | CARDI000051 | 2.91 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 803 | FUT3 levels | PROLV000837 | 2.91 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 804 | Epilepsy | NEURO000034 | 2.90 | Neurologic | Myeloid | 0 | 2 | 5 | 19 | |
| 805 | Open wound | DERMA000043 | 2.90 | Dermatologic | Neural / glial | 1 | 3 | 7 | 6 | |
| 806 | SYT1 levels | PROLV001985 | 2.89 | Protein levels | Granulosa cell | 25 | 1 | 6 | 12 | |
| 807 | Muscle fat infiltration | BCOMP000011 | 2.88 | Body composition | Myeloid | 40 | 2 | 8 | 20 | |
| 808 | LTBP2/PDGFRA ratio | PRORT001465 | 2.88 | Protein ratios | Myeloid | 4 | 3 | 9 | 8 | |
| 809 | CNTNAP4 levels | PROLV000481 | 2.88 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 810 | FCRL2/KLB ratio | PRORT001129 | 2.87 | Protein ratios | Hepatocyte | 35 | 1 | 5 | 11 | |
| 811 | Fat-free mass | BCOMP000008 | 2.87 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 812 | COMP/THBS4 ratio | PRORT000714 | 2.86 | Protein ratios | Neural / glial | 1 | 5 | 15 | 26 | |
| 813 | Chronic kidney disease | NEPHR000001 | 2.86 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 814 | GFRA1/SPON2 ratio | PRORT001208 | 2.86 | Protein ratios | Hepatocyte | 3 | 1 | 6 | 11 | |
| 815 | C2/LILRB4 ratio | PRORT000264 | 2.86 | Protein ratios | Myeloid | 71 | 3 | 11 | 24 | |
| 816 | MOG/RTBDN ratio | PRORT001552 | 2.86 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 817 | DFFA levels | PROLV000615 | 2.86 | Protein levels | Stromal / connective | 1 | 3 | 10 | 13 | |
| 818 | SERPINC1 levels | PROLV001828 | 2.84 | Protein levels | Hepatocyte | 51 | 1 | 7 | 16 | |
| 819 | P4HB levels | PROLV001481 | 2.84 | Protein levels | Stromal / connective | 66 | 2 | 7 | 26 | |
| 820 | NT5C1A levels | PROLV001439 | 2.83 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 821 | Snoring | RESPI000036 | 2.83 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 822 | Premature cardiac beat | CARDI000023 | 2.83 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 823 | Steroid metabolite | METAB000073 | 2.82 | Metabolites | Hepatocyte | 38 | 1 | 3 | 13 | |
| 824 | GDNF levels | PROLV000872 | 2.82 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 825 | Breast disorder | BREAS000002 | 2.81 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 826 | Iris and ciliary body disorder | OPHTH000005 | 2.81 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 827 | CTBS levels | PROLV000554 | 2.81 | Protein levels | Stromal / connective | 57 | 3 | 10 | 20 | |
| 828 | Abdominal aortic calcification | VASCU000051 | 2.80 | Vascular | Vascular | 0 | 1 | 4 | 11 | |
| 829 | Bacterial intestinal infection | IMMUN000052 | 2.80 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 830 | SDC4/WWP2 ratio | PRORT001769 | 2.80 | Protein ratios | Myeloid | 11 | 3 | 10 | 19 | |
| 831 | HSPB1 levels | PROLV000997 | 2.79 | Protein levels | Platelet | 16 | 3 | 3 | 13 | |
| 832 | CELA3A/CPB1 ratio | PRORT000594 | 2.79 | Protein ratios | Vascular | 26 | 1 | 3 | 10 | |
| 833 | Peripheral vascular disease | VASCU000043 | 2.79 | Vascular | Stromal / connective | 65 | 3 | 6 | 14 | |
| 834 | CCN3/PGF ratio | PRORT000374 | 2.79 | Protein ratios | Vascular | 2 | 4 | 6 | 28 | |
| 835 | DCN levels | PROLV000601 | 2.79 | Protein levels | Myeloid | 65 | 3 | 10 | 14 | |
| 836 | PMVK/PRDX5 ratio | PRORT001692 | 2.78 | Protein ratios | Myeloid | 1 | 4 | 11 | 25 | |
| 837 | Family history, Alzheimer disease | NEURO000007 | 2.77 | Neurologic | Vascular | 35 | 0 | 1 | 3 | |
| 838 | PTP4A3 levels | PROLV001670 | 2.75 | Protein levels | Myeloid | 2 | 2 | 16 | 21 | |
| 839 | EGLN1/PSIP1 ratio | PRORT001005 | 2.74 | Protein ratios | Myeloid | 0 | 0 | 3 | 8 | |
| 840 | PKLR/UBAC1 ratio | PRORT001669 | 2.74 | Protein ratios | Muscle / cardiac | 11 | 1 | 7 | 8 | |
| 841 | CD164/NUDT5 ratio | PRORT000388 | 2.74 | Protein ratios | Myeloid | 6 | 3 | 8 | 10 | |
| 842 | ADGRE2/CD58 ratio | PRORT000028 | 2.74 | Protein ratios | Myeloid | 43 | 3 | 11 | 17 | |
| 843 | COL9A1 levels | PROLV000493 | 2.74 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 844 | Cancer, Oesophagus | MALIG000021 | 2.73 | Malignancy | Salivary epithelium | 1 | 0 | 2 | 4 | |
| 845 | CLMP/GFRA1 ratio | PRORT000668 | 2.73 | Protein ratios | Hepatocyte | 49 | 2 | 9 | 18 | |
| 846 | SLPI levels | PROLV001892 | 2.73 | Protein levels | Cutaneous epithelium | 0 | 0 | 11 | 9 | |
| 847 | FAM172A levels | PROLV000762 | 2.72 | Protein levels | Stromal / connective | 9 | 2 | 9 | 24 | |
| 848 | MASP1 levels | PROLV001276 | 2.72 | Protein levels | Hepatocyte | 99 | 1 | 7 | 7 | |
| 849 | BCAM levels | PROLV000181 | 2.72 | Protein levels | Hepatocyte | 79 | 2 | 14 | 15 | |
| 850 | SERPINA4 levels | PROLV001818 | 2.71 | Protein levels | Hepatocyte | 96 | 1 | 7 | 4 | |
| 851 | MB levels | PROLV001281 | 2.70 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 852 | ANGPTL4 levels | PROLV000098 | 2.69 | Protein levels | Hepatocyte | 49 | 3 | 9 | 23 | |
| 853 | PLA2G2A levels | PROLV001568 | 2.68 | Protein levels | Myeloid | 20 | 3 | 9 | 17 | |
| 854 | Cortical thickness | NIMAG000010 | 2.68 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 855 | Trihexosylceramides | LIPID000073 | 2.68 | Lipids | Granulosa cell | 7 | 2 | 5 | 4 | |
| 856 | Optic disc area | OPHTH000029 | 2.68 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 857 | CST3/IGFBP6 ratio | PRORT000783 | 2.67 | Protein ratios | Stromal / connective | 7 | 3 | 15 | 19 | |
| 858 | Weight, birth | BMORP000018 | 2.66 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 859 | Pregnancy complication, haemorrhage | REPRO000030 | 2.66 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 860 | IL4R levels | PROLV001075 | 2.66 | Protein levels | Hepatocyte | 92 | 2 | 11 | 15 | |
| 861 | Arm mass | BCOMP000014 | 2.66 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 862 | F3 levels | PROLV000746 | 2.65 | Protein levels | Vascular | 50 | 0 | 8 | 7 | |
| 863 | CACNB3 levels | PROLV000251 | 2.64 | Protein levels | Vascular | 2 | 1 | 3 | 18 | |
| 864 | SUSD2 levels | PROLV001979 | 2.64 | Protein levels | B / plasma cell | 15 | 3 | 8 | 14 | |
| 865 | Gut microbial abundance, Holdemania | GASTR000026 | 2.64 | Gastrointestinal | Hepatocyte | 0 | 3 | 13 | 24 | |
| 866 | Medication use, pain etc, none | MISCL000032 | 2.64 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 867 | OSMR levels | PROLV001476 | 2.63 | Protein levels | Lymphocyte | 78 | 3 | 14 | 34 | |
| 868 | MMP3 levels | PROLV001325 | 2.63 | Protein levels | Myeloid | 51 | 1 | 6 | 8 | |
| 869 | Choroid plexus volume | NIMAG000020 | 2.62 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 870 | ASAH2 levels | PROLV000150 | 2.61 | Protein levels | Myeloid | 115 | 3 | 7 | 17 | |
| 871 | PAM levels | PROLV001492 | 2.61 | Protein levels | Myeloid | 112 | 2 | 11 | 21 | |
| 872 | SIGLEC9 levels | PROLV001865 | 2.61 | Protein levels | Hepatocyte | 118 | 1 | 6 | 11 | |
| 873 | FUS levels | PROLV000836 | 2.60 | Protein levels | Vascular | 2 | 5 | 11 | 21 | |
| 874 | TLR4 levels | PROLV002044 | 2.60 | Protein levels | Lymphocyte | 0 | 1 | 6 | 23 | |
| 875 | Osteoarthritis, OA | MSKEL000012 | 2.60 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 876 | PINLYP levels | PROLV001562 | 2.59 | Protein levels | Myeloid | 66 | 4 | 10 | 14 | |
| 877 | MEPE levels | PROLV001299 | 2.58 | Protein levels | Muscle / cardiac | 39 | 2 | 7 | 17 | |
| 878 | IRF3 levels | PROLV001100 | 2.58 | Protein levels | Neural / glial | 0 | 3 | 6 | 12 | |
| 879 | Polycythaemia | HEMAT000012 | 2.58 | Hematologic | Vascular | 2 | 2 | 7 | 14 | |
| 880 | GMPR2 levels | PROLV000903 | 2.57 | Protein levels | Lymphocyte | 3 | 3 | 11 | 40 | |
| 881 | Gut microbial abundance, Olsenella C | GASTR000030 | 2.56 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 882 | Operation, respiratory | RESPI000025 | 2.56 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 883 | Systemic lupus erythematosus, SLE | IMMUN000020 | 2.55 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 884 | Brain general volume | NIMAG000015 | 2.55 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 885 | LAMB1 levels | PROLV001179 | 2.55 | Protein levels | Stromal / connective | 44 | 2 | 9 | 22 | |
| 886 | HLA-DRA levels | PROLV000975 | 2.55 | Protein levels | Myeloid | 117 | 3 | 8 | 14 | |
| 887 | Amino acid metabolites | METAB000002 | 2.54 | Metabolites | Neural / glial | 0 | 0 | 7 | 11 | |
| 888 | CDCP1/MSR1 ratio | PRORT000544 | 2.53 | Protein ratios | Myeloid | 26 | 2 | 10 | 13 | |
| 889 | Spondylopathy | MSKEL000080 | 2.53 | Musculoskeletal | Stromal / connective | 21 | 2 | 2 | 10 | |
| 890 | CCL17/CCL22 ratio | PRORT000342 | 2.53 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 31 | |
| 891 | SLC9A3R2 levels | PROLV001886 | 2.53 | Protein levels | Vascular | 16 | 2 | 7 | 14 | |
| 892 | Dihydrosphingomyelins | LIPID000067 | 2.52 | Lipids | Epithelial | 0 | 0 | 6 | 10 | |
| 893 | UBE2L6 levels | PROLV002133 | 2.51 | Protein levels | Stromal / connective | 2 | 3 | 9 | 31 | |
| 894 | CD4/LILRB4 ratio | PRORT000441 | 2.51 | Protein ratios | Myeloid | 61 | 4 | 11 | 12 | |
| 895 | CLIP2/NT5C3A ratio | PRORT000667 | 2.50 | Protein ratios | Muscle / cardiac | 0 | 4 | 5 | 13 | |
| 896 | ARF6 levels | PROLV000133 | 2.50 | Protein levels | Stromal / connective | 50 | 5 | 15 | 21 | |
| 897 | Spine surgery | MSKEL000051 | 2.50 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 898 | GLRX5 levels | PROLV000898 | 2.50 | Protein levels | Stromal / connective | 3 | 3 | 6 | 16 | |
| 899 | VGF levels | PROLV002161 | 2.50 | Protein levels | Hepatocyte | 30 | 1 | 5 | 9 | |
| 900 | CD83/TREM2 ratio | PRORT000519 | 2.50 | Protein ratios | Myeloid | 56 | 3 | 11 | 15 | |
| 901 | SESTD1 levels | PROLV001838 | 2.50 | Protein levels | Muscle / cardiac | 12 | 4 | 8 | 23 | |
| 902 | BMPER levels | PROLV000206 | 2.50 | Protein levels | Myeloid | 1 | 1 | 8 | 12 | |
| 903 | NMT1 levels | PROLV001412 | 2.49 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 904 | TNFRSF12A levels | PROLV002062 | 2.49 | Protein levels | Epithelial | 11 | 0 | 7 | 6 | |
| 905 | Height decline | BMORP000010 | 2.49 | Body morphology | Hepatocyte | 1 | 2 | 6 | 13 | |
| 906 | CCN2/MGLL ratio | PRORT000366 | 2.48 | Protein ratios | Myeloid | 9 | 4 | 12 | 19 | |
| 907 | ORM1 levels | PROLV001473 | 2.48 | Protein levels | Myeloid | 16 | 1 | 9 | 12 | |
| 908 | Pyrimidine metabolites | METAB000063 | 2.48 | Metabolites | Granulosa cell | 0 | 1 | 7 | 16 | |
| 909 | CTSF/NAAA ratio | PRORT000801 | 2.48 | Protein ratios | Hepatocyte | 46 | 3 | 13 | 23 | |
| 910 | C1QTNF5 levels | PROLV000225 | 2.48 | Protein levels | Myeloid | 120 | 2 | 5 | 10 | |
| 911 | Ganglion cell inner plexiform layer thickness | OPHTH000027 | 2.47 | Ophthalmic | Renal epithelium | 10 | 0 | 6 | 5 | |
| 912 | GALNT10/IGSF3 ratio | PRORT001201 | 2.47 | Protein ratios | Hepatocyte | 8 | 3 | 11 | 21 | |
| 913 | IDS/SMPDL3A ratio | PRORT001330 | 2.47 | Protein ratios | Hepatocyte | 53 | 2 | 8 | 19 | |
| 914 | Cancer, Lung | MALIG000019 | 2.45 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 915 | MSTN/RGMA ratio | PRORT001564 | 2.45 | Protein ratios | Muscle / cardiac | 12 | 2 | 12 | 27 | |
| 916 | AGRN/BTN2A1 ratio | PRORT000046 | 2.44 | Protein ratios | Adipose | 70 | 2 | 7 | 7 | |
| 917 | HMOX2/TDRKH ratio | PRORT001291 | 2.44 | Protein ratios | Stromal / connective | 0 | 3 | 7 | 16 | |
| 918 | BLVRB/HMBS ratio | PRORT000243 | 2.44 | Protein ratios | Neural / glial | 14 | 5 | 14 | 29 | |
| 919 | Coagulation disorder | HEMAT000017 | 2.44 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 920 | ACAN levels | PROLV000010 | 2.43 | Protein levels | Stromal / connective | 76 | 3 | 7 | 17 | |
| 921 | PRUNE2 levels | PROLV001652 | 2.42 | Protein levels | Hepatocyte | 23 | 1 | 3 | 15 | |
| 922 | NT5C3A/PRDX5 ratio | PRORT001602 | 2.42 | Protein ratios | Myeloid | 0 | 2 | 8 | 14 | |
| 923 | CCN5/IGFBP6 ratio | PRORT000375 | 2.41 | Protein ratios | Stromal / connective | 6 | 1 | 3 | 18 | |
| 924 | HS1BP3 levels | PROLV000989 | 2.40 | Protein levels | Stromal / connective | 24 | 6 | 12 | 24 | |
| 925 | GORASP2 levels | PROLV000911 | 2.39 | Protein levels | Vascular | 13 | 2 | 7 | 27 | |
| 926 | TCN1 levels | PROLV002003 | 2.39 | Protein levels | Myeloid | 74 | 3 | 9 | 13 | |
| 927 | BMP4 levels | PROLV000203 | 2.39 | Protein levels | Granulosa cell | 46 | 2 | 8 | 26 | |
| 928 | Metabolon metabolite | METAB000076 | 2.39 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 929 | CD164 levels | PROLV000313 | 2.39 | Protein levels | Myeloid | 20 | 2 | 10 | 12 | |
| 930 | CD300C/LRRC25 ratio | PRORT000426 | 2.38 | Protein ratios | Myeloid | 55 | 2 | 7 | 10 | |
| 931 | PRSS53 levels | PROLV001647 | 2.38 | Protein levels | Hepatocyte | 56 | 2 | 9 | 25 | |
| 932 | DNAJB1/STIP1 ratio | PRORT000930 | 2.37 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 12 | |
| 933 | Cancer, Cervix | MALIG000012 | 2.37 | Malignancy | Lymphocyte | 23 | 0 | 4 | 30 | |
| 934 | BCAN/KLK6 ratio | PRORT000216 | 2.36 | Protein ratios | Myeloid | 11 | 2 | 7 | 12 | |
| 935 | Intestinal disorder | GASTR000012 | 2.36 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 936 | Gestational age at birth | REPRO000040 | 2.36 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 937 | ANXA4/LACTB2 ratio | PRORT000112 | 2.35 | Protein ratios | Myeloid | 0 | 3 | 7 | 11 | |
| 938 | Sex-differentiated cardiometabolic traits | MISCL000002 | 2.34 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 939 | AXL/VCAM1 ratio | PRORT000183 | 2.33 | Protein ratios | Myeloid | 85 | 4 | 15 | 37 | |
| 940 | Heart rate response to exercise | CARDI000025 | 2.33 | Cardiac | Vascular | 12 | 0 | 6 | 5 | |
| 941 | MED18/SMAD1 ratio | PRORT001509 | 2.33 | Protein ratios | Hepatocyte | 2 | 4 | 15 | 37 | |
| 942 | MIA levels | PROLV001311 | 2.33 | Protein levels | Neural / glial | 91 | 4 | 7 | 14 | |
| 943 | HMBS/PKLR ratio | PRORT001288 | 2.33 | Protein ratios | Lymphocyte | 29 | 1 | 15 | 23 | |
| 944 | GFRA1 levels | PROLV000876 | 2.33 | Protein levels | Myeloid | 22 | 2 | 8 | 15 | |
| 945 | PGLS levels | PROLV001545 | 2.32 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 946 | APRT/NSFL1C ratio | PRORT000136 | 2.31 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 947 | CA1/TGM2 ratio | PRORT000270 | 2.30 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 948 | Stroke | VASCU000017 | 2.30 | Vascular | Vascular | 37 | 2 | 4 | 11 | |
| 949 | GRAP2/PLPBP ratio | PRORT001242 | 2.29 | Protein ratios | Hepatocyte | 1 | 3 | 8 | 17 | |
| 950 | NRSN1 levels | PROLV001436 | 2.29 | Protein levels | Lymphocyte | 0 | 2 | 14 | 32 | |
| 951 | IDUA levels | PROLV001013 | 2.29 | Protein levels | Hepatocyte | 160 | 1 | 6 | 10 | |
| 952 | PTGES2 levels | PROLV001665 | 2.28 | Protein levels | Myeloid | 1 | 3 | 13 | 21 | |
| 953 | PODXL levels | PROLV001595 | 2.28 | Protein levels | Vascular | 18 | 1 | 5 | 12 | |
| 954 | Organic acid metabolites | METAB000067 | 2.28 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 955 | CX3CL1/LAYN ratio | PRORT000809 | 2.28 | Protein ratios | Vascular | 12 | 2 | 9 | 12 | |
| 956 | TMSB10/TREML2 ratio | PRORT001839 | 2.28 | Protein ratios | Myeloid | 1 | 2 | 8 | 13 | |
| 957 | NCR3LG1 levels | PROLV001384 | 2.27 | Protein levels | Hepatocyte | 32 | 1 | 8 | 15 | |
| 958 | LRPAP1 levels | PROLV001231 | 2.27 | Protein levels | Vascular | 92 | 3 | 8 | 20 | |
| 959 | TRAF3 levels | PROLV002100 | 2.27 | Protein levels | B / plasma cell | 18 | 2 | 14 | 29 | |
| 960 | CD27/CD79B ratio | PRORT000411 | 2.26 | Protein ratios | B / plasma cell | 12 | 3 | 15 | 22 | |
| 961 | CST6/NECTIN4 ratio | PRORT000792 | 2.26 | Protein ratios | Epithelial | 3 | 1 | 5 | 13 | |
| 962 | CLMP/TGFBR2 ratio | PRORT000670 | 2.25 | Protein ratios | Adipose | 11 | 2 | 6 | 6 | |
| 963 | Passive smoking | MISCL000007 | 2.25 | Miscellaneous | Neural / glial | 0 | 3 | 8 | 18 | |
| 964 | CKMB levels | PROLV000441 | 2.24 | Protein levels | Muscle / cardiac | 9 | 3 | 10 | 26 | |
| 965 | ESAM/VSIR ratio | PRORT001070 | 2.24 | Protein ratios | Vascular | 7 | 2 | 10 | 16 | |
| 966 | BTN2A1/LILRB4 ratio | PRORT000258 | 2.23 | Protein ratios | Myeloid | 77 | 3 | 10 | 14 | |
| 967 | LAMA4/NID1 ratio | PRORT001419 | 2.23 | Protein ratios | Vascular | 14 | 5 | 12 | 24 | |
| 968 | ERN1 levels | PROLV000730 | 2.23 | Protein levels | Hepatocyte | 95 | 3 | 8 | 18 | |
| 969 | SELE levels | PROLV001803 | 2.23 | Protein levels | Vascular | 55 | 2 | 4 | 14 | |
| 970 | DKK4/REG1A ratio | PRORT000909 | 2.23 | Protein ratios | Hepatocyte | 32 | 2 | 8 | 16 | |
| 971 | Purine metabolites | METAB000062 | 2.21 | Metabolites | Hepatocyte | 3 | 1 | 5 | 13 | |
| 972 | FEV1/FVC ratio | RESPI000021 | 2.21 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 973 | HHV7 U14 antibody | IMMUN000063 | 2.21 | Immunologic | Lymphocyte | 4 | 1 | 13 | 39 | |
| 974 | RAP1A levels | PROLV001704 | 2.21 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 975 | Lysophosphatidylcholines | LIPID000054 | 2.21 | Lipids | Neural / glial | 26 | 2 | 4 | 15 | |
| 976 | DIABLO/PRKAR1A ratio | PRORT000893 | 2.20 | Protein ratios | Myeloid | 12 | 3 | 12 | 18 | |
| 977 | Aplastic anaemia | HEMAT000004 | 2.20 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 978 | Hypoxaemia | RESPI000029 | 2.20 | Respiratory | Vascular | 15 | 2 | 13 | 27 | |
| 979 | MPO levels | PROLV001336 | 2.20 | Protein levels | Myeloid | 55 | 2 | 5 | 10 | |
| 980 | ACRBP levels | PROLV000016 | 2.18 | Protein levels | Lymphocyte | 3 | 2 | 7 | 20 | |
| 981 | ADD1 levels | PROLV000039 | 2.18 | Protein levels | Lymphocyte | 1 | 1 | 9 | 31 | |
| 982 | CCL13/CCL17 ratio | PRORT000337 | 2.18 | Protein ratios | Myeloid | 17 | 3 | 8 | 27 | |
| 983 | GRP levels | PROLV000934 | 2.18 | Protein levels | Granulosa cell | 6 | 2 | 3 | 7 | |
| 984 | GBA1 levels | PROLV000859 | 2.18 | Protein levels | Myeloid | 0 | 2 | 8 | 20 | |
| 985 | CD55/CHI3L1 ratio | PRORT000469 | 2.18 | Protein ratios | Hepatocyte | 11 | 2 | 9 | 24 | |
| 986 | CD55/ITGB1 ratio | PRORT000470 | 2.17 | Protein ratios | Vascular | 51 | 2 | 8 | 22 | |
| 987 | TDRKH levels | PROLV002008 | 2.17 | Protein levels | Vascular | 14 | 4 | 6 | 16 | |
| 988 | CD99/MMP3 ratio | PRORT000535 | 2.16 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 989 | FCER1A levels | PROLV000776 | 2.16 | Protein levels | Myeloid | 18 | 3 | 21 | 40 | |
| 990 | PEPD levels | PROLV001536 | 2.16 | Protein levels | Myeloid | 66 | 2 | 7 | 7 | |
| 991 | WASHC3 levels | PROLV002186 | 2.16 | Protein levels | Myeloid | 11 | 2 | 6 | 14 | |
| 992 | Free androgen index | ENDOC000007 | 2.15 | Endocrine | Hepatocyte | 616 | 1 | 6 | 20 | |
| 993 | ENAH levels | PROLV000702 | 2.14 | Protein levels | Vascular | 0 | 1 | 6 | 20 | |
| 994 | Acne | DERMA000028 | 2.14 | Dermatologic | Cutaneous epithelium | 14 | 0 | 8 | 7 | |
| 995 | SFTPA1 levels | PROLV001847 | 2.14 | Protein levels | B / plasma cell | 0 | 0 | 3 | 9 | |
| 996 | AK2 levels | PROLV000071 | 2.13 | Protein levels | Myeloid | 13 | 2 | 5 | 16 | |
| 997 | Pustular skin disorder | DERMA000018 | 2.13 | Dermatologic | Hepatocyte | 0 | 1 | 5 | 13 | |
| 998 | TALDO1 levels | PROLV001991 | 2.13 | Protein levels | Lymphocyte | 8 | 3 | 10 | 40 | |
| 999 | PEAR1/SNAP23 ratio | PRORT001659 | 2.13 | Protein ratios | Neural / glial | 1 | 2 | 9 | 26 | |
| 1000 | Shift work | SOCIO000008 | 2.12 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 |